MEKK2
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S95 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | RPHKVDGRVVEPKRAVSREDsQRPDAHLTVKKIFVGGIKED |
| O00165 | S153 | Sugiyama | HAX1 HS1BP1 | PDSHQPRIFGGVLESDARSEsPQPAPDWGsQRPFHRFDDVW |
| O15047 | S470 | Sugiyama | SETD1A KIAA0339 KMT2F SET1 SET1A | sPEREEVRtsPRPAsPARsGsPAPEttNESVPFAQHSSLDS |
| O43707 | T443 | Sugiyama | ACTN4 | sIHEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDL |
| O43852 | T89 | Sugiyama | CALU | sKERLGKIVSKIDGDKDGFVtVDELKDWIKFAQKRWIyEDV |
| O60716 | S252 | Sugiyama | CTNND1 KIAA0384 | sRVtRIEERyRPsMEGyRAPsRQDVyGPQPQVRVGGssVDL |
| O95757 | T82 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | NTIHGFKKLHGRsFDDPIVQtERIRLPYELQKMPNGSAGVK |
| P00338 | T322 | Sugiyama | LDHA PIG19 | DLVKVTLtsEEEARLKKsADtLWGIQKELQF__________ |
| P00558 | T168 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGF |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04406 | T246 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKVVKQAS |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07205 | T168 | Sugiyama | PGK2 PGKB | EAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNLPHKASGF |
| P07900 | S53 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDsG |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P09651 | S95 | Sugiyama | HNRNPA1 HNRPA1 | RPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| P09972 | T125 | Sugiyama | ALDOC ALDC | VGIKVDKGVVPLAGtDGEtttQGLDGLsERCAQYKKDGADF |
| P0DPH7 | T334 | Sugiyama | TUBA3C TUBA2 | ACCMLYRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11142 | T66 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQsD |
| P12270 | T1518 | Sugiyama | TPR | ENLQKTLSEKETEARNLQEQtVQLQSELSRLRQDLQDRTTQ |
| P12814 | T424 | Sugiyama | ACTN1 | sIHEAWtDGKEAMLRQKDyEtAtLsEIKALLKKHEAFEsDL |
| P13489 | T176 | Sugiyama | RNH1 PRI RNH | AASCEPLASVLRAKPDFKELtVsNNDINEAGVRVLCQGLKD |
| P13987 | T76 | Sugiyama | CD59 MIC11 MIN1 MIN2 MIN3 MSK21 | AGLQVYNKCWKFEHCNFNDVtTRLRENELtyyCCKKDLCNF |
| P15170 | T315 | Sugiyama | GSPT1 ERF3A | NRSVDGPIRLPIVDKYKDMGtVVLGKLESGSICKGQQLVMM |
| P16070 | T76 | Sugiyama | CD44 LHR MDU2 MDU3 MIC4 | FNSTLPTMAQMEKALsIGFEtCRyGFIEGHVVIPRIHPNSI |
| P17812 | S575 | Sugiyama | CTPS1 CTPS | LQKGCRLsPRDtysDRsGsssPDsEItELKFPsINHD____ |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P29692 | S162 | Sugiyama | EEF1D EF1D | AKKPAtPAEDDEDDDIDLFGsDNEEEDKEAAQLREERLRQY |
| P30086 | S60 | Sugiyama | PEBP1 PBP PEBP | VLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPK |
| P30101 | T485 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KKyEGGRELsDFIsyLQREAtNPPVIQEEKPKKKKKAQEDL |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P31949 | T33 | Sugiyama | S100A11 MLN70 S100C | CIESLIAVFQKYAGKDGyNytLsKtEFLsFMNTELAAFTKN |
| P35222 | S675 | EPSD|PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | AAAVLFRMSEDKPQDyKKRLsVELtssLFRTEPMAWNETAD |
| P35269 | T389 | Sugiyama | GTF2F1 RAP74 | PPKRERKPsGGSSRGNsRPGtPsAEGGstsstLRAAASKLE |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P38117 | T172 | Sugiyama | ETFB FP585 | QVTLEGDKLKVEREIDGGLEtLRLKLPAVVTADLRLNEPRy |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P38646 | T398 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | SDIGEVILVGGMTRMPKVQQtVQDLFGRAPsKAVNPDEAVA |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P42166 | T160 | Sugiyama | TMPO LAP2 | KLYEKKLLKLREQGtEsRsstPLPtIsssAENtRQNGsNDs |
| P42167 | T160 | Sugiyama | TMPO LAP2 | KLYEKKLLKLREQGTESRsstPLPTISsSAENTRQNGSNDS |
| P45985 | S257 | GPS6 | MAP2K4 JNKK1 MEK4 MKK4 PRKMK4 SEK1 SERK1 SKK1 | LDRSGNIKLCDFGIsGQLVDsIAKtRDAGCRPyMAPERIDP |
| P45985 | T261 | GPS6 | MAP2K4 JNKK1 MEK4 MKK4 PRKMK4 SEK1 SERK1 SKK1 | GNIKLCDFGIsGQLVDsIAKtRDAGCRPyMAPERIDPSASR |
| P47712 | S724 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | NIDVIKEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFL |
| P47712 | S729 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | KEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFLSKPKA |
| P50395 | T408 | Sugiyama | GDI2 RABGDIB | VPKDLGtEsQIFIsRTyDAttHFEttCDDIKNIYKRMtGsE |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P60174 | T90 | Sugiyama | TPI1 TPI | VTNGAFtGEIsPGMIKDCGAtWVVLGHsERRHVFGEsDELI |
| P60660 | T103 | Sugiyama | MYL6 | QGtyEDyVEGLRVFDKEGNGtVMGAEIRHVLVtLGEKMTEE |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P61254 | T8 | Sugiyama | RPL26 | _____________MKFNPFVtsDRsKNRKRHFNAPsHIRRK |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62263 | T133 | Sugiyama | RPS14 PRO2640 | QsALRALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL__ |
| P62424 | T84 | Sugiyama | RPL7A SURF-3 SURF3 | QRQRAILyKRLKVPPAINQFtQALDRQTAtQLLKLAHKYRP |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62826 | T21 | Sugiyama | RAN ARA24 OK/SW-cl.81 | MAAQGEPQVQFKLVLVGDGGtGKttFVKRHLtGEFEKKyVA |
| P62942 | T7 | Sugiyama | FKBP1A FKBP1 FKBP12 | ______________MGVQVEtIsPGDGRtFPKRGQtCVVHy |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P63167 | T26 | Sugiyama | DYNLL1 DLC1 DNCL1 DNCLC1 HDLC1 | AVIKNADMsEEMQQDsVECAtQALEKYNIEKDIAAHIKKEF |
| P63173 | T14 | Sugiyama | RPL38 | _______MPRKIEEIKDFLLtARRKDAKSVKIKKNKDNVKF |
| P63220 | S68 | Sugiyama | RPS21 | GQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF_____ |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68363 | T334 | Sugiyama | TUBA1B | ACCLLyRGDVVPKDVNAAIAtIKtKRsIQFVDWCPTGFKVG |
| P68363 | T80 | Sugiyama | TUBA1B | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| P78371 | T246 | Sugiyama | CCT2 99D8.1 CCTB | VNQPKRIENAKILIANtGMDtDKIKIFGsRVRVDstAKVAE |
| P85037 | S420 | Sugiyama | FOXK1 MNF | RGVSCFRtPFGPLssRsAPAsPtHPGLMsPRsGGLQtPECL |
| P85037 | S428 | Sugiyama | FOXK1 MNF | PFGPLssRsAPAsPtHPGLMsPRsGGLQtPECLsREGsPIP |
| Q02750 | S218 | ELM | MAP2K1 MEK1 PRKMK1 | VNSRGEIKLCDFGVsGQLIDsMANsFVGtRSYMsPERLQGT |
| Q02750 | S222 | ELM | MAP2K1 MEK1 PRKMK1 | GEIKLCDFGVsGQLIDsMANsFVGtRSYMsPERLQGTHYSV |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q13283 | S232 | Sugiyama | G3BP1 G3BP | EEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsWA |
| Q13283 | T241 | Sugiyama | G3BP1 G3BP | ETAPEDAQKsssPAPADIAQtVQEDLRtFsWAsVtsKNLPP |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14247 | T328 | Sugiyama | CTTN EMS1 | GKyGVQKDRMDKNAstFEDVtQVssAyQKTVPVEAVtsKts |
| Q14568 | S53 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | IINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDSG |
| Q14653 | S173 | EPSD|PSP | IRF3 | PDPGPPSLAVAPEPCPQPLRsPsLDNPtPFPNLGPsENPLK |
| Q15208 | S91 | PSP | STK38 NDR1 | RKEtEFLRLKRTRLGLEDFEsLKVIGRGAFGEVRLVQKKDT |
| Q15293 | T100 | Sugiyama | RCN1 RCN | sKERLGKIVDRIDNDGDGFVttEELKtWIKRVQKRyIFDNV |
| Q15427 | T14 | Sugiyama | SF3B4 SAP49 | _______MAAGPISERNQDAtVyVGGLDEKVSEPLLWELFL |
| Q27J81 | T1206 | Sugiyama | INF2 C14orf151 C14orf173 | DtsLDKsFsEDAVtDssGsGtLPRARGRASKGTGKRRKKRP |
| Q32P51 | S95 | Sugiyama | HNRNPA1L2 HNRNPA1L | TPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| Q53EL6 | S94 | Sugiyama | PDCD4 H731 | GDsVsDsGsDALRSGLtVPtsPKGRLLDRRSRSGKGRGLPK |
| Q6PEY2 | T334 | Sugiyama | TUBA3E | ACCMLYRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| Q6UN15 | S492 | Sugiyama | FIP1L1 FIP1 RHE | DRDRDRERERTRERERERDHsPtPsVFNsDEERyRYREYAE |
| Q6UN15 | T494 | Sugiyama | FIP1L1 FIP1 RHE | DRDRERERTRERERERDHsPtPsVFNsDEERyRYREYAERG |
| Q71U36 | T334 | Sugiyama | TUBA1A TUBA3 | ACCLLyRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| Q71U36 | T80 | Sugiyama | TUBA1A TUBA3 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q7Z2W4 | T294 | Sugiyama | ZC3HAV1 ZC3HDC2 PRO1677 | PsPDQIsHRAsLEDAPVDDLtRKFtyLGsQDRARPPsGsSK |
| Q86VQ1 | S223 | Sugiyama | GLCCI1 | QTPsCWAEEGAEKRSHQRsAsWGsADQLKEQIAKLRQQLQR |
| Q8IWW6 | S240 | Sugiyama | ARHGAP12 | SSSsTEQIRAttPPNQGRPDsPVyANLQELKISQSALPPLP |
| Q8IWW6 | T231 | Sugiyama | ARHGAP12 | QDSEsGDELSSSsTEQIRAttPPNQGRPDsPVyANLQELKI |
| Q8IYD1 | T444 | Sugiyama | GSPT2 ERF3B | NRSIDGPIRLPIVDKYKDMGtVVLGKLESGSIFKGQQLVMM |
| Q8IZ21 | S118 | Sugiyama | PHACTR4 PRO2963 | PSDAMLKNGHTTPIGNARsssPVQVEEEPVRLAsLRKAIPE |
| Q8N3A8 | T355 | Sugiyama | PARP8 | KSHRTFGRsLSSDPRAEQAMtAIKSHKLLNRPCPAAVKsEE |
| Q8N684 | T203 | Sugiyama | CPSF7 | GGIPPRAHsRDssDsADGRAtPsENLVPSSARVDKPPSVLP |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q96AE4 | S52 | Sugiyama | FUBP1 | KDALQRARQIAAKIGGDAGtsLNsNDyGyGGQKRPLEDGDQ |
| Q96MH2 | S76 | Sugiyama | HEXIM2 L3 | EDLAGAVGGLGWNsRsPRtQsPGGCsAEAVLARKKHRRRPS |
| Q96S44 | T8 | Sugiyama | TP53RK C20orf64 PRPK | _____________MAAARAttPADGEEPAPEAEALAAARER |
| Q99627 | T158 | Sugiyama | COPS8 CSN8 | GLPVEEAVKGILEQGWQADstTRMVLPRKPVAGALDVsFNK |
| Q99759 | S399 | Sugiyama | MAP3K3 MAPKKK3 MEKK3 | CYDVDtGRELASKQVQFDPDsPETSKEVSALECEIQLLKNL |
| Q9BQE3 | T334 | Sugiyama | TUBA1C TUBA6 | ACCLLyRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| Q9BQE3 | T80 | Sugiyama | TUBA1C TUBA6 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q9C0C2 | S672 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | TLARAETtQARtEAQDLCRAsPEPPGPEsSSRWLDDLLAsP |
| Q9H173 | T123 | Sugiyama | SIL1 UNQ545/PRO836 | KLQYEDKFRNNLKGKRLDINtNtytsQDLKSALAKFKEGAE |
| Q9H173 | T125 | Sugiyama | SIL1 UNQ545/PRO836 | QYEDKFRNNLKGKRLDINtNtytsQDLKSALAKFKEGAEME |
| Q9H173 | Y126 | Sugiyama | SIL1 UNQ545/PRO836 | YEDKFRNNLKGKRLDINtNtytsQDLKSALAKFKEGAEMES |
| Q9H4A3 | S1261 | Sugiyama | WNK1 HSN2 KDP KIAA0344 PRKWNK1 | GIPTSSLTQVVHSAGRRFIVsPVPEsRLRESKVFPSEITDT |
| Q9H6F5 | S91 | Sugiyama | CCDC86 CYCLON | RLQQGAGLEsPQGQPEPGAAsPQRQQDLHLEsPQRQPEysP |
| Q9NQE9 | T47 | Sugiyama | HINT3 | ssVGTCEAAGKsPEPKDyDstCVFCRIAGRQDPGTELLHCE |
| Q9NWB6 | S77 | Sugiyama | ARGLU1 | RsRstNTAVSRRERDRERAssPPDRIDIFGRTVSKRSSLDE |
| Q9NY27 | S311 | Sugiyama | PPP4R2 SBBI57 | CTRQHCtEEDEEEDEEEEEEsFMtsREMIPERKNQEKESDD |
| Q9NY27 | S315 | Sugiyama | PPP4R2 SBBI57 | HCtEEDEEEDEEEEEEsFMtsREMIPERKNQEKESDDALTV |
| Q9NY27 | T314 | Sugiyama | PPP4R2 SBBI57 | QHCtEEDEEEDEEEEEEsFMtsREMIPERKNQEKESDDALT |
| Q9UBW7 | T157 | Sugiyama | ZMYM2 FIM RAMP ZNF198 | NFIERRPPETKNRTNDVDFStSSFSRSKVNAGMGNSGITTE |
| Q9UNX3 | T8 | Sugiyama | RPL26L1 RPL26P1 | _____________MKFNPFVtsDRsKNRKRHFNAPSHVRRK |
| Q9UQ35 | S1103 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sPsLQSKSQTsPKGGRsRsssPVtELAsRsPIRQDRGEFsA |
| Q9UQ35 | S1648 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | APRALPRRSRSGSSSKGRGPsPEGssstEssPEHPPKSRTA |
| Q9UQ35 | S2132 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | SRMsCFsRPsMsPtPLDRCRsPGMLEPLGssRtPMsVLQQA |
| Q9UQ35 | S351 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | PssPYEDKDKDKKEKsAtRPsPsPERsstGPEPPAPtPLLA |
| Q9UQ35 | S353 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sPYEDKDKDKKEKsAtRPsPsPERsstGPEPPAPtPLLAER |
| Q9UQ35 | S876 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | tsPQANEQsVtPQRRsCFEssPDPELKsRtPsRHsCsGssP |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2U5 | S393 | Sugiyama | MAP3K2 MAPKKK2 MEKK2 | CYDVDTGRELAVKQVQFDPDsPETSKEVNALECEIQLLKNL |
| Q9Y2U5 | S514 | Sugiyama | MAP3K2 MAPKKK2 MEKK2 | TGNVKLGDFGASKRLQtICLsGtGMKsVtGtPYWMSPEVIS |
| Q9Y2U5 | T510 | Sugiyama | MAP3K2 MAPKKK2 MEKK2 | LRDSTGNVKLGDFGASKRLQtICLsGtGMKsVtGtPYWMSP |
| Q9Y2U5 | T516 | Sugiyama | MAP3K2 MAPKKK2 MEKK2 | NVKLGDFGASKRLQtICLsGtGMKsVtGtPYWMSPEVISGE |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Axon guidance | R-HSA-422475 | 1.677087e-09 | 8.775 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.607461e-08 | 7.794 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 4.300557e-08 | 7.366 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.517388e-07 | 6.599 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 2.513474e-07 | 6.600 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.980016e-07 | 6.526 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 4.853756e-06 | 5.314 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.327990e-05 | 4.633 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 3.303128e-05 | 4.481 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 4.222507e-05 | 4.374 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 4.267114e-04 | 3.370 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 4.267114e-04 | 3.370 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 5.217425e-04 | 3.283 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 5.535763e-04 | 3.257 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 6.651721e-04 | 3.177 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 6.582316e-04 | 3.182 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 9.682617e-04 | 3.014 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 1.469726e-03 | 2.833 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.673380e-03 | 2.776 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.673380e-03 | 2.776 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.780407e-03 | 2.749 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.052634e-03 | 2.688 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.586286e-03 | 2.587 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 3.095261e-03 | 2.509 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 4.245040e-03 | 2.372 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 4.245040e-03 | 2.372 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 4.173831e-03 | 2.379 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 4.173831e-03 | 2.379 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.197537e-03 | 2.377 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 4.196101e-03 | 2.377 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 3.941198e-03 | 2.404 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 3.658125e-03 | 2.437 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 4.818308e-03 | 2.317 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 4.861069e-03 | 2.313 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 5.236505e-03 | 2.281 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 5.765820e-03 | 2.239 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 6.286742e-03 | 2.202 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 6.357148e-03 | 2.197 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 6.286742e-03 | 2.202 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 6.305368e-03 | 2.200 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 6.477159e-03 | 2.189 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 6.663815e-03 | 2.176 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 6.672477e-03 | 2.176 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 7.045130e-03 | 2.152 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 7.400567e-03 | 2.131 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 8.308991e-03 | 2.080 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 8.051630e-03 | 2.094 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 8.051630e-03 | 2.094 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 8.383866e-03 | 2.077 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 9.317941e-03 | 2.031 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 9.953125e-03 | 2.002 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.015414e-02 | 1.993 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.082285e-02 | 1.966 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.082285e-02 | 1.966 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 1.082285e-02 | 1.966 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.434213e-02 | 1.843 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.434213e-02 | 1.843 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.434213e-02 | 1.843 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.434213e-02 | 1.843 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.434213e-02 | 1.843 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.434213e-02 | 1.843 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.434213e-02 | 1.843 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.434213e-02 | 1.843 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.434213e-02 | 1.843 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.434213e-02 | 1.843 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.434213e-02 | 1.843 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.394071e-02 | 1.856 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.394071e-02 | 1.856 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.414194e-02 | 1.849 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.274007e-02 | 1.895 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.210100e-02 | 1.917 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.259404e-02 | 1.900 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.406294e-02 | 1.852 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.271729e-02 | 1.896 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.438833e-02 | 1.842 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.212061e-02 | 1.916 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.451610e-02 | 1.838 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 1.751663e-02 | 1.757 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.737938e-02 | 1.760 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.640797e-02 | 1.785 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.638317e-02 | 1.786 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.638317e-02 | 1.786 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.754822e-02 | 1.756 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.854538e-02 | 1.732 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 2.176060e-02 | 1.662 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 2.176060e-02 | 1.662 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 2.155617e-02 | 1.666 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 2.155617e-02 | 1.666 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 2.155617e-02 | 1.666 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.898521e-02 | 1.722 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.082319e-02 | 1.681 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.191532e-02 | 1.659 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.896760e-02 | 1.722 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.155617e-02 | 1.666 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 2.155617e-02 | 1.666 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 2.176060e-02 | 1.662 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 2.335994e-02 | 1.632 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 2.457003e-02 | 1.610 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.687513e-02 | 1.571 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.742973e-02 | 1.562 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 2.915585e-02 | 1.535 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 3.101791e-02 | 1.508 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.938178e-02 | 1.532 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 3.099159e-02 | 1.509 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 3.103066e-02 | 1.508 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 3.103066e-02 | 1.508 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 3.103066e-02 | 1.508 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 3.107345e-02 | 1.508 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 3.246501e-02 | 1.489 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.295155e-02 | 1.482 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.295155e-02 | 1.482 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 3.646014e-02 | 1.438 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 3.646014e-02 | 1.438 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.609524e-02 | 1.443 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 3.344893e-02 | 1.476 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 4.396615e-02 | 1.357 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 4.396615e-02 | 1.357 | 0 | 0 |
| IRS activation | R-HSA-74713 | 4.022995e-02 | 1.395 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 3.994995e-02 | 1.398 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 4.022995e-02 | 1.395 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 4.332794e-02 | 1.363 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 4.022995e-02 | 1.395 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 4.022995e-02 | 1.395 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 4.234307e-02 | 1.373 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 4.377234e-02 | 1.359 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 4.313589e-02 | 1.365 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 4.022995e-02 | 1.395 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 4.292631e-02 | 1.367 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.485224e-02 | 1.348 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 4.660345e-02 | 1.332 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 4.731814e-02 | 1.325 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 4.795888e-02 | 1.319 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 4.795888e-02 | 1.319 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 5.104103e-02 | 1.292 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 4.867058e-02 | 1.313 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 5.104103e-02 | 1.292 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 5.232999e-02 | 1.281 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 5.104103e-02 | 1.292 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 5.443788e-02 | 1.264 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 5.104103e-02 | 1.292 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 5.285267e-02 | 1.277 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 5.104103e-02 | 1.292 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 5.084761e-02 | 1.294 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 5.451748e-02 | 1.263 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 8.600184e-02 | 1.065 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 8.600184e-02 | 1.065 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 8.600184e-02 | 1.065 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 8.600184e-02 | 1.065 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 8.600184e-02 | 1.065 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 8.600184e-02 | 1.065 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 1.261917e-01 | 0.899 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 1.261917e-01 | 0.899 | 0 | 0 |
| XAV939 stabilizes AXIN | R-HSA-5545619 | 1.261917e-01 | 0.899 | 0 | 0 |
| Defective AVP does not bind AVPR1A,B and causes neurohypophyseal diabetes insipidus (NDI) | R-HSA-5619099 | 1.261917e-01 | 0.899 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 1.261917e-01 | 0.899 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 1.261917e-01 | 0.899 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 1.646167e-01 | 0.784 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 1.646167e-01 | 0.784 | 0 | 0 |
| Defective PAPSS2 causes SEMD-PA | R-HSA-3560796 | 1.646167e-01 | 0.784 | 0 | 0 |
| Defective SLC12A1 causes Bartter syndrome 1 (BS1) | R-HSA-5619104 | 1.646167e-01 | 0.784 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 6.275679e-02 | 1.202 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 7.527701e-02 | 1.123 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 7.527701e-02 | 1.123 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 7.527701e-02 | 1.123 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 2.013542e-01 | 0.696 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 2.013542e-01 | 0.696 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 2.013542e-01 | 0.696 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 2.013542e-01 | 0.696 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.023648e-01 | 0.990 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 1.023648e-01 | 0.990 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.023648e-01 | 0.990 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 2.364783e-01 | 0.626 | 0 | 0 |
| Nucleotide catabolism defects | R-HSA-9735786 | 2.364783e-01 | 0.626 | 0 | 0 |
| Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine | R-HSA-9735763 | 2.364783e-01 | 0.626 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 2.364783e-01 | 0.626 | 0 | 0 |
| Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate | R-HSA-2978092 | 2.364783e-01 | 0.626 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.364783e-01 | 0.626 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 2.364783e-01 | 0.626 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 1.167655e-01 | 0.933 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 6.261456e-02 | 1.203 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.316361e-01 | 0.881 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 1.316361e-01 | 0.881 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 2.700596e-01 | 0.569 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.469076e-01 | 0.833 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.469076e-01 | 0.833 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 1.625161e-01 | 0.789 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.625161e-01 | 0.789 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.625161e-01 | 0.789 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.625161e-01 | 0.789 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.625161e-01 | 0.789 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.625161e-01 | 0.789 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.625161e-01 | 0.789 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 3.021659e-01 | 0.520 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 3.021659e-01 | 0.520 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 3.021659e-01 | 0.520 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 3.021659e-01 | 0.520 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 1.784026e-01 | 0.749 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.234044e-01 | 0.909 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 1.945127e-01 | 0.711 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 3.328619e-01 | 0.478 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 3.328619e-01 | 0.478 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 1.333836e-01 | 0.875 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 2.107959e-01 | 0.676 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 2.107959e-01 | 0.676 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.107959e-01 | 0.676 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 1.541298e-01 | 0.812 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.622094e-01 | 0.441 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 3.622094e-01 | 0.441 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 3.622094e-01 | 0.441 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 3.622094e-01 | 0.441 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 3.622094e-01 | 0.441 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.230648e-01 | 0.910 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.387262e-01 | 0.858 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.869401e-01 | 0.728 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.869401e-01 | 0.728 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.869401e-01 | 0.728 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.869401e-01 | 0.728 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.602405e-01 | 0.585 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.602405e-01 | 0.585 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 2.602405e-01 | 0.585 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 3.902677e-01 | 0.409 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 3.902677e-01 | 0.409 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 3.902677e-01 | 0.409 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.108627e-01 | 0.955 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 1.982545e-01 | 0.703 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.982545e-01 | 0.703 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.982545e-01 | 0.703 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 2.097279e-01 | 0.678 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 6.519615e-02 | 1.186 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 6.519615e-02 | 1.186 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 1.636023e-01 | 0.786 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.040674e-01 | 0.983 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.040674e-01 | 0.983 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 2.213431e-01 | 0.655 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 4.170932e-01 | 0.380 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 1.810117e-01 | 0.742 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.810117e-01 | 0.742 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 1.810117e-01 | 0.742 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 1.810117e-01 | 0.742 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.199331e-01 | 0.921 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.330831e-01 | 0.632 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.330831e-01 | 0.632 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 3.097886e-01 | 0.509 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.311372e-01 | 0.882 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 1.990012e-01 | 0.701 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.568720e-01 | 0.590 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 3.261809e-01 | 0.487 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 3.261809e-01 | 0.487 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 3.261809e-01 | 0.487 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.427400e-01 | 0.354 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 4.427400e-01 | 0.354 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 4.427400e-01 | 0.354 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 2.175007e-01 | 0.663 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 2.175007e-01 | 0.663 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 2.175007e-01 | 0.663 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.864695e-01 | 0.729 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.864695e-01 | 0.729 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.612039e-01 | 0.793 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.269198e-01 | 0.644 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.269198e-01 | 0.644 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.269198e-01 | 0.644 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 3.424681e-01 | 0.465 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 3.424681e-01 | 0.465 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 3.424681e-01 | 0.465 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 3.424681e-01 | 0.465 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 2.809682e-01 | 0.551 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.739954e-01 | 0.759 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 6.198259e-02 | 1.208 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 3.174325e-01 | 0.498 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 8.574445e-02 | 1.067 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.296184e-01 | 0.482 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 3.904851e-01 | 0.408 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.904851e-01 | 0.408 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.539618e-01 | 0.451 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.498670e-01 | 0.824 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.732305e-01 | 0.563 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 4.368708e-01 | 0.360 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 4.368708e-01 | 0.360 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 4.368708e-01 | 0.360 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 3.902374e-01 | 0.409 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 3.902374e-01 | 0.409 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 2.972398e-01 | 0.527 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 3.686953e-01 | 0.433 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 4.410910e-01 | 0.355 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 4.410910e-01 | 0.355 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 1.311372e-01 | 0.882 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 4.216146e-01 | 0.375 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 3.686953e-01 | 0.433 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 2.662117e-01 | 0.575 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 2.213431e-01 | 0.655 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.539618e-01 | 0.451 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 4.410910e-01 | 0.355 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 2.107959e-01 | 0.676 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 2.038716e-01 | 0.691 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 3.626473e-01 | 0.441 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.167655e-01 | 0.933 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 3.255423e-01 | 0.487 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.651203e-01 | 0.577 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 3.555422e-01 | 0.449 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.884504e-01 | 0.540 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.011131e-01 | 0.995 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 1.023648e-01 | 0.990 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.011131e-01 | 0.995 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.539618e-01 | 0.451 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 3.904851e-01 | 0.408 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 3.660963e-01 | 0.436 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.449314e-01 | 0.611 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 8.654682e-02 | 1.063 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 8.850852e-02 | 1.053 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.011131e-01 | 0.995 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.810117e-01 | 0.742 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 3.781916e-01 | 0.422 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.167655e-01 | 0.933 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.700596e-01 | 0.569 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 6.316147e-02 | 1.200 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 2.602405e-01 | 0.585 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 3.586277e-01 | 0.445 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.417987e-01 | 0.466 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 4.415689e-01 | 0.355 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 3.507667e-01 | 0.455 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.048783e-01 | 0.979 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.175007e-01 | 0.663 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.269198e-01 | 0.644 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.795273e-01 | 0.746 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.675479e-01 | 0.776 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.023648e-01 | 0.990 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 2.364783e-01 | 0.626 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.469076e-01 | 0.833 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 9.526583e-02 | 1.021 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 9.526583e-02 | 1.021 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 2.107959e-01 | 0.676 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 3.902677e-01 | 0.409 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 5.913272e-02 | 1.228 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.330831e-01 | 0.632 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 4.368708e-01 | 0.360 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 8.900034e-02 | 1.051 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 5.800757e-02 | 1.237 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 3.261809e-01 | 0.487 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 2.767898e-01 | 0.558 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 2.257280e-01 | 0.646 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 3.700685e-01 | 0.432 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 5.800757e-02 | 1.237 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 9.423542e-02 | 1.026 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.363785e-01 | 0.865 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 7.527701e-02 | 1.123 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.364783e-01 | 0.626 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 3.021659e-01 | 0.520 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.328619e-01 | 0.478 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 3.622094e-01 | 0.441 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 3.622094e-01 | 0.441 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 1.648596e-01 | 0.783 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 2.767898e-01 | 0.558 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 8.013199e-02 | 1.096 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.809682e-01 | 0.551 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 1.745346e-01 | 0.758 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 1.745346e-01 | 0.758 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 1.745346e-01 | 0.758 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 8.117851e-02 | 1.091 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.899383e-01 | 0.721 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.810117e-01 | 0.742 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.541298e-01 | 0.812 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 3.430078e-01 | 0.465 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.272061e-01 | 0.644 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 2.338607e-01 | 0.631 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.297704e-01 | 0.887 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.715196e-01 | 0.766 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.119678e-01 | 0.951 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.541298e-01 | 0.812 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.959478e-01 | 0.529 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.173657e-01 | 0.663 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 6.261456e-02 | 1.203 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 3.021659e-01 | 0.520 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 3.328619e-01 | 0.478 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 3.622094e-01 | 0.441 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 2.602405e-01 | 0.585 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 3.586277e-01 | 0.445 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 2.655229e-01 | 0.576 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.265988e-01 | 0.645 | 0 | 0 |
| Vasopressin-like receptors | R-HSA-388479 | 2.364783e-01 | 0.626 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.316700e-01 | 0.881 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 4.259852e-01 | 0.371 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 2.809682e-01 | 0.551 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 1.307979e-01 | 0.883 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 3.424681e-01 | 0.465 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.262940e-01 | 0.645 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 3.762223e-01 | 0.425 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 3.507667e-01 | 0.455 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 6.342109e-02 | 1.198 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 3.052535e-01 | 0.515 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 8.654682e-02 | 1.063 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 2.097279e-01 | 0.678 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.230912e-01 | 0.910 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 3.052535e-01 | 0.515 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 8.792514e-02 | 1.056 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.323229e-01 | 0.878 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 1.261917e-01 | 0.899 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 1.261917e-01 | 0.899 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 1.261917e-01 | 0.899 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 2.013542e-01 | 0.696 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.364783e-01 | 0.626 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 1.167655e-01 | 0.933 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.316361e-01 | 0.881 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 2.700596e-01 | 0.569 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.469076e-01 | 0.833 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.625161e-01 | 0.789 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 3.021659e-01 | 0.520 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 3.021659e-01 | 0.520 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 3.021659e-01 | 0.520 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 3.021659e-01 | 0.520 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 3.328619e-01 | 0.478 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.333836e-01 | 0.875 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 2.602405e-01 | 0.585 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 3.902677e-01 | 0.409 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 3.902677e-01 | 0.409 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 2.767898e-01 | 0.558 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 4.170932e-01 | 0.380 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 1.810117e-01 | 0.742 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 2.688893e-01 | 0.570 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 7.759628e-02 | 1.110 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 3.586277e-01 | 0.445 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 3.174325e-01 | 0.498 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 4.368708e-01 | 0.360 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.015928e-01 | 0.696 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 3.757186e-01 | 0.425 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 3.271922e-01 | 0.485 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 4.259852e-01 | 0.371 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 2.488513e-01 | 0.604 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 2.526553e-01 | 0.597 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 4.141431e-01 | 0.383 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 2.526553e-01 | 0.597 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 2.714199e-01 | 0.566 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 2.097279e-01 | 0.678 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 4.141431e-01 | 0.383 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 4.141431e-01 | 0.383 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 3.417987e-01 | 0.466 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.539618e-01 | 0.451 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 2.714199e-01 | 0.566 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 8.792591e-02 | 1.056 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.298124e-01 | 0.887 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 3.326373e-01 | 0.478 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.544643e-01 | 0.811 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 7.027106e-02 | 1.153 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 2.097279e-01 | 0.678 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.663937e-01 | 0.574 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.520452e-01 | 0.818 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.043271e-01 | 0.982 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 7.501067e-02 | 1.125 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 8.117851e-02 | 1.091 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.902677e-01 | 0.409 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 4.061484e-01 | 0.391 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 3.539618e-01 | 0.451 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 3.539618e-01 | 0.451 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 3.539618e-01 | 0.451 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 3.539618e-01 | 0.451 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 3.763529e-01 | 0.424 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 4.061484e-01 | 0.391 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.146690e-01 | 0.668 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 1.737355e-01 | 0.760 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 6.275679e-02 | 1.202 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 1.023648e-01 | 0.990 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 1.023648e-01 | 0.990 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 5.543188e-02 | 1.256 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.021659e-01 | 0.520 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.784026e-01 | 0.749 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.622094e-01 | 0.441 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 1.108627e-01 | 0.955 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.688893e-01 | 0.570 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 2.557502e-01 | 0.592 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 3.656344e-01 | 0.437 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 3.113300e-01 | 0.507 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.011131e-01 | 0.995 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 9.340691e-02 | 1.030 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.564978e-01 | 0.591 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.056229e-01 | 0.976 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 3.113300e-01 | 0.507 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.406655e-01 | 0.852 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 2.763817e-01 | 0.558 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.486532e-01 | 0.604 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 5.985999e-02 | 1.223 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.298124e-01 | 0.887 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 4.061484e-01 | 0.391 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.737355e-01 | 0.760 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 9.841843e-02 | 1.007 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.940504e-01 | 0.712 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 2.840230e-01 | 0.547 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 2.840230e-01 | 0.547 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.387262e-01 | 0.858 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.941163e-01 | 0.712 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.732305e-01 | 0.563 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 3.982183e-01 | 0.400 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.636023e-01 | 0.786 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.939260e-01 | 0.712 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 1.770533e-01 | 0.752 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 8.961757e-02 | 1.048 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.023648e-01 | 0.990 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 2.364783e-01 | 0.626 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 3.021659e-01 | 0.520 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 1.784026e-01 | 0.749 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 2.107959e-01 | 0.676 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 3.622094e-01 | 0.441 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 3.622094e-01 | 0.441 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 3.622094e-01 | 0.441 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 3.902677e-01 | 0.409 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 2.933158e-01 | 0.533 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 2.568720e-01 | 0.590 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 4.427400e-01 | 0.354 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.864695e-01 | 0.729 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 4.061484e-01 | 0.391 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 3.656344e-01 | 0.437 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.712925e-01 | 0.567 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 3.903039e-01 | 0.409 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.185181e-01 | 0.661 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.722302e-01 | 0.764 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 1.234044e-01 | 0.909 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 4.349175e-01 | 0.362 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 4.410910e-01 | 0.355 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 3.982183e-01 | 0.400 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.688168e-01 | 0.773 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 3.113300e-01 | 0.507 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 3.781916e-01 | 0.422 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 2.160270e-01 | 0.665 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 3.958378e-01 | 0.402 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.224930e-01 | 0.912 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 3.417987e-01 | 0.466 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 3.857885e-01 | 0.414 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 2.106545e-01 | 0.676 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.224930e-01 | 0.912 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.224930e-01 | 0.912 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 7.906209e-02 | 1.102 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 1.152800e-01 | 0.938 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 1.276715e-01 | 0.894 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 8.490071e-02 | 1.071 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.545832e-01 | 0.594 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 6.275679e-02 | 1.202 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.328619e-01 | 0.478 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.933158e-01 | 0.533 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 4.170932e-01 | 0.380 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.809682e-01 | 0.551 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 3.660963e-01 | 0.436 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 4.368708e-01 | 0.360 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 3.857885e-01 | 0.414 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 4.194230e-01 | 0.377 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.792028e-01 | 0.747 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 1.824811e-01 | 0.739 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.036558e-01 | 0.984 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.933158e-01 | 0.533 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.211813e-02 | 1.207 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.437006e-01 | 0.613 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 3.097886e-01 | 0.509 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 4.259852e-01 | 0.371 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 4.259852e-01 | 0.371 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 3.750356e-01 | 0.426 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.503645e-01 | 0.601 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.869883e-01 | 0.542 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 3.350300e-01 | 0.475 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 3.847741e-01 | 0.415 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 3.373159e-01 | 0.472 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.813252e-01 | 0.742 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.464941e-01 | 0.608 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.285966e-01 | 0.891 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 7.527701e-02 | 1.123 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 8.850852e-02 | 1.053 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 2.364783e-01 | 0.626 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 1.167655e-01 | 0.933 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.469076e-01 | 0.833 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 8.654682e-02 | 1.063 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 3.021659e-01 | 0.520 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.945127e-01 | 0.711 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 3.328619e-01 | 0.478 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 2.272061e-01 | 0.644 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 3.622094e-01 | 0.441 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 3.622094e-01 | 0.441 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 3.902677e-01 | 0.409 | 0 | 0 |
| PKA activation | R-HSA-163615 | 2.767898e-01 | 0.558 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 4.170932e-01 | 0.380 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 4.170932e-01 | 0.380 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 4.427400e-01 | 0.354 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 3.424681e-01 | 0.465 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 2.809682e-01 | 0.551 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.539618e-01 | 0.451 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.539618e-01 | 0.451 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 3.660963e-01 | 0.436 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 4.216146e-01 | 0.375 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 3.575322e-01 | 0.447 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.193340e-01 | 0.923 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 2.568720e-01 | 0.590 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 6.342109e-02 | 1.198 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 3.097886e-01 | 0.509 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 3.261809e-01 | 0.487 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 4.328763e-01 | 0.364 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.056229e-01 | 0.976 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 7.572312e-02 | 1.121 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 3.639949e-01 | 0.439 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 2.784579e-01 | 0.555 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 5.543188e-02 | 1.256 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 4.170932e-01 | 0.380 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 4.170932e-01 | 0.380 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.097277e-01 | 0.678 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 2.655229e-01 | 0.576 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 3.823876e-01 | 0.417 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.216211e-01 | 0.915 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.642265e-01 | 0.785 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 2.076701e-01 | 0.683 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 2.303750e-01 | 0.638 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 3.574915e-01 | 0.447 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.316361e-01 | 0.881 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 3.904851e-01 | 0.408 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 3.296184e-01 | 0.482 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 8.792591e-02 | 1.056 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 7.527701e-02 | 1.123 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.023648e-01 | 0.990 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 1.023648e-01 | 0.990 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.700596e-01 | 0.569 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 3.021659e-01 | 0.520 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 3.021659e-01 | 0.520 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 3.328619e-01 | 0.478 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 3.328619e-01 | 0.478 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.107959e-01 | 0.676 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 1.436316e-01 | 0.843 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 2.437006e-01 | 0.613 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 4.170932e-01 | 0.380 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 3.586277e-01 | 0.445 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 3.296184e-01 | 0.482 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.824811e-01 | 0.739 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 4.377425e-01 | 0.359 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 4.216146e-01 | 0.375 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.739954e-01 | 0.759 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 4.279845e-01 | 0.369 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 2.930943e-01 | 0.533 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.492259e-01 | 0.826 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 3.996257e-01 | 0.398 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 2.229099e-01 | 0.652 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.107959e-01 | 0.676 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 4.170932e-01 | 0.380 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 4.170932e-01 | 0.380 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 4.427400e-01 | 0.354 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 3.417987e-01 | 0.466 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 3.252861e-01 | 0.488 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.081916e-01 | 0.682 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 3.459767e-01 | 0.461 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 8.261820e-02 | 1.083 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 3.656344e-01 | 0.437 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 1.092278e-01 | 0.962 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 3.857885e-01 | 0.414 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 1.784026e-01 | 0.749 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 3.586277e-01 | 0.445 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 6.792492e-02 | 1.168 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 9.905865e-02 | 1.004 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.792238e-01 | 0.554 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 4.022243e-01 | 0.396 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 9.526583e-02 | 1.021 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 3.021659e-01 | 0.520 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 3.902677e-01 | 0.409 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 2.767898e-01 | 0.558 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 4.170932e-01 | 0.380 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 3.261809e-01 | 0.487 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 4.427400e-01 | 0.354 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 4.427400e-01 | 0.354 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 2.930943e-01 | 0.533 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 3.052535e-01 | 0.515 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 4.216146e-01 | 0.375 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.464941e-01 | 0.608 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 3.656344e-01 | 0.437 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 3.656344e-01 | 0.437 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 3.656344e-01 | 0.437 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 3.656344e-01 | 0.437 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 3.450505e-01 | 0.462 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 4.259852e-01 | 0.371 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 5.907696e-02 | 1.229 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.052535e-01 | 0.515 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.452148e-01 | 0.838 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 3.490951e-01 | 0.457 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 2.437006e-01 | 0.613 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 4.170932e-01 | 0.380 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.052535e-01 | 0.515 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 4.376515e-01 | 0.359 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 3.186645e-01 | 0.497 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 3.781916e-01 | 0.422 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 1.155347e-01 | 0.937 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 2.809682e-01 | 0.551 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.746395e-01 | 0.426 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 3.902374e-01 | 0.409 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 4.259852e-01 | 0.371 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 2.651203e-01 | 0.577 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.167655e-01 | 0.933 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.982183e-01 | 0.400 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 1.234044e-01 | 0.909 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.052535e-01 | 0.515 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 3.296184e-01 | 0.482 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 4.022243e-01 | 0.396 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 3.417987e-01 | 0.466 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.660963e-01 | 0.436 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 3.424681e-01 | 0.465 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.417987e-01 | 0.466 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 3.902677e-01 | 0.409 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.424681e-01 | 0.465 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 4.357114e-01 | 0.361 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.216146e-01 | 0.375 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.582128e-01 | 0.588 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 3.038432e-01 | 0.517 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.933158e-01 | 0.533 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.377425e-01 | 0.359 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 3.417987e-01 | 0.466 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 3.555422e-01 | 0.449 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 3.746395e-01 | 0.426 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 4.455714e-01 | 0.351 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 4.455714e-01 | 0.351 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 4.494075e-01 | 0.347 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 4.519056e-01 | 0.345 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 4.519056e-01 | 0.345 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 4.519056e-01 | 0.345 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 4.519056e-01 | 0.345 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 4.533052e-01 | 0.344 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 4.570456e-01 | 0.340 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 4.609730e-01 | 0.336 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 4.651260e-01 | 0.332 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 4.667090e-01 | 0.331 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 4.667090e-01 | 0.331 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 4.672600e-01 | 0.330 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 4.672600e-01 | 0.330 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 4.672600e-01 | 0.330 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 4.672600e-01 | 0.330 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 4.672600e-01 | 0.330 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 4.672600e-01 | 0.330 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 4.672600e-01 | 0.330 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 4.672600e-01 | 0.330 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 4.672600e-01 | 0.330 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 4.672600e-01 | 0.330 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 4.674410e-01 | 0.330 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 4.674410e-01 | 0.330 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 4.709635e-01 | 0.327 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 4.710881e-01 | 0.327 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 4.724325e-01 | 0.326 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 4.724325e-01 | 0.326 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 4.724325e-01 | 0.326 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 4.748112e-01 | 0.323 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 4.768798e-01 | 0.322 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 4.812722e-01 | 0.318 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 4.812722e-01 | 0.318 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 4.812722e-01 | 0.318 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 4.812722e-01 | 0.318 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 4.839700e-01 | 0.315 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 4.842876e-01 | 0.315 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 4.842876e-01 | 0.315 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 4.844294e-01 | 0.315 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 4.844294e-01 | 0.315 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 4.844294e-01 | 0.315 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 4.844294e-01 | 0.315 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 4.907024e-01 | 0.309 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 4.907024e-01 | 0.309 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 4.907024e-01 | 0.309 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 4.907024e-01 | 0.309 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 4.907024e-01 | 0.309 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 4.907024e-01 | 0.309 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 4.907024e-01 | 0.309 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 4.930569e-01 | 0.307 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 4.950089e-01 | 0.305 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 4.955453e-01 | 0.305 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 4.955453e-01 | 0.305 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 4.955877e-01 | 0.305 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.955877e-01 | 0.305 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 4.955877e-01 | 0.305 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 5.013328e-01 | 0.300 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 5.061149e-01 | 0.296 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 5.061149e-01 | 0.296 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 5.061149e-01 | 0.296 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 5.061149e-01 | 0.296 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 5.061149e-01 | 0.296 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 5.096491e-01 | 0.293 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 5.096491e-01 | 0.293 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 5.128410e-01 | 0.290 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 5.131147e-01 | 0.290 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 5.131147e-01 | 0.290 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 5.131147e-01 | 0.290 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 5.131147e-01 | 0.290 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 5.131147e-01 | 0.290 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 5.131147e-01 | 0.290 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 5.131147e-01 | 0.290 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 5.131147e-01 | 0.290 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 5.131147e-01 | 0.290 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 5.131147e-01 | 0.290 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 5.131147e-01 | 0.290 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 5.131147e-01 | 0.290 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 5.131147e-01 | 0.290 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 5.131147e-01 | 0.290 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 5.131147e-01 | 0.290 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 5.170927e-01 | 0.286 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 5.170927e-01 | 0.286 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 5.170927e-01 | 0.286 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.221517e-01 | 0.282 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 5.234511e-01 | 0.281 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 5.234511e-01 | 0.281 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 5.234511e-01 | 0.281 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 5.261930e-01 | 0.279 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 5.279379e-01 | 0.277 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 5.313768e-01 | 0.275 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 5.345420e-01 | 0.272 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 5.345420e-01 | 0.272 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 5.345420e-01 | 0.272 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 5.345420e-01 | 0.272 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 5.345420e-01 | 0.272 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 5.345420e-01 | 0.272 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 5.345420e-01 | 0.272 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 5.345420e-01 | 0.272 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 5.345420e-01 | 0.272 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.345420e-01 | 0.272 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 5.345420e-01 | 0.272 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 5.345420e-01 | 0.272 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 5.345420e-01 | 0.272 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 5.369788e-01 | 0.270 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 5.369893e-01 | 0.270 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 5.369893e-01 | 0.270 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 5.369893e-01 | 0.270 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 5.369893e-01 | 0.270 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 5.369893e-01 | 0.270 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 5.370611e-01 | 0.270 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 5.386464e-01 | 0.269 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 5.386464e-01 | 0.269 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 5.386464e-01 | 0.269 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 5.405762e-01 | 0.267 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 5.492144e-01 | 0.260 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 5.492144e-01 | 0.260 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 5.502601e-01 | 0.259 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 5.502601e-01 | 0.259 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 5.502601e-01 | 0.259 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 5.502601e-01 | 0.259 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 5.502601e-01 | 0.259 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 5.502601e-01 | 0.259 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 5.502601e-01 | 0.259 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 5.502601e-01 | 0.259 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 5.504959e-01 | 0.259 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 5.504959e-01 | 0.259 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 5.530846e-01 | 0.257 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 5.530846e-01 | 0.257 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 5.550275e-01 | 0.256 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 5.550275e-01 | 0.256 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 5.550275e-01 | 0.256 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 5.550275e-01 | 0.256 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 5.550275e-01 | 0.256 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 5.550275e-01 | 0.256 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 5.550275e-01 | 0.256 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 5.559978e-01 | 0.255 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 5.596386e-01 | 0.252 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 5.632609e-01 | 0.249 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 5.632609e-01 | 0.249 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 5.632609e-01 | 0.249 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 5.632609e-01 | 0.249 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 5.663579e-01 | 0.247 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.699160e-01 | 0.244 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 5.746127e-01 | 0.241 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 5.746127e-01 | 0.241 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 5.746127e-01 | 0.241 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 5.746127e-01 | 0.241 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 5.746127e-01 | 0.241 | 0 | 0 |
| Transport and metabolism of PAPS | R-HSA-174362 | 5.746127e-01 | 0.241 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 5.746127e-01 | 0.241 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 5.746127e-01 | 0.241 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 5.746127e-01 | 0.241 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.746127e-01 | 0.241 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 5.759897e-01 | 0.240 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 5.759897e-01 | 0.240 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 5.759897e-01 | 0.240 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 5.759897e-01 | 0.240 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 5.800438e-01 | 0.237 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 5.861035e-01 | 0.232 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 5.884453e-01 | 0.230 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 5.884453e-01 | 0.230 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 5.884453e-01 | 0.230 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 5.884453e-01 | 0.230 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 5.884453e-01 | 0.230 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 5.896014e-01 | 0.229 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 5.896014e-01 | 0.229 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 5.900198e-01 | 0.229 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 5.933224e-01 | 0.227 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 5.933369e-01 | 0.227 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 5.933369e-01 | 0.227 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 5.933369e-01 | 0.227 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 5.933369e-01 | 0.227 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 5.933369e-01 | 0.227 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.933369e-01 | 0.227 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.933369e-01 | 0.227 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 5.933369e-01 | 0.227 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 5.933369e-01 | 0.227 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 5.933369e-01 | 0.227 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 5.933369e-01 | 0.227 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 5.933369e-01 | 0.227 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 5.933369e-01 | 0.227 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 5.933369e-01 | 0.227 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 5.959231e-01 | 0.225 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 5.998419e-01 | 0.222 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 5.998419e-01 | 0.222 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 6.006271e-01 | 0.221 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 6.006271e-01 | 0.221 | 0 | 0 |
| Depurination | R-HSA-73927 | 6.006271e-01 | 0.221 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 6.006271e-01 | 0.221 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 6.012872e-01 | 0.221 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 6.047111e-01 | 0.218 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 6.083009e-01 | 0.216 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 6.095083e-01 | 0.215 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 6.095083e-01 | 0.215 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 6.095083e-01 | 0.215 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 6.112381e-01 | 0.214 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 6.112381e-01 | 0.214 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 6.112381e-01 | 0.214 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 6.112381e-01 | 0.214 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 6.112381e-01 | 0.214 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 6.112381e-01 | 0.214 | 0 | 0 |
| Heme assimilation | R-HSA-9927020 | 6.112381e-01 | 0.214 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 6.112381e-01 | 0.214 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 6.112381e-01 | 0.214 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 6.112381e-01 | 0.214 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 6.125351e-01 | 0.213 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 6.125351e-01 | 0.213 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 6.125351e-01 | 0.213 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 6.144242e-01 | 0.212 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 6.178219e-01 | 0.209 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 6.241697e-01 | 0.205 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 6.241697e-01 | 0.205 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 6.241697e-01 | 0.205 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 6.267679e-01 | 0.203 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 6.283522e-01 | 0.202 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 6.283522e-01 | 0.202 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.283522e-01 | 0.202 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 6.283522e-01 | 0.202 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 6.283522e-01 | 0.202 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 6.283522e-01 | 0.202 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.283682e-01 | 0.202 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 6.302059e-01 | 0.201 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 6.344688e-01 | 0.198 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 6.355319e-01 | 0.197 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 6.355319e-01 | 0.197 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 6.355319e-01 | 0.197 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 6.438969e-01 | 0.191 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 6.447140e-01 | 0.191 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 6.447140e-01 | 0.191 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.447140e-01 | 0.191 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 6.447140e-01 | 0.191 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 6.447140e-01 | 0.191 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 6.447140e-01 | 0.191 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 6.447140e-01 | 0.191 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 6.447140e-01 | 0.191 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 6.447140e-01 | 0.191 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 6.447140e-01 | 0.191 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 6.447140e-01 | 0.191 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 6.540362e-01 | 0.184 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 6.554610e-01 | 0.183 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 6.574454e-01 | 0.182 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 6.574454e-01 | 0.182 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 6.574454e-01 | 0.182 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 6.574454e-01 | 0.182 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 6.574454e-01 | 0.182 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 6.594098e-01 | 0.181 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 6.600272e-01 | 0.180 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 6.603564e-01 | 0.180 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 6.603564e-01 | 0.180 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 6.603564e-01 | 0.180 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.603564e-01 | 0.180 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.603564e-01 | 0.180 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 6.603564e-01 | 0.180 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 6.603564e-01 | 0.180 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 6.603564e-01 | 0.180 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 6.603564e-01 | 0.180 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 6.603564e-01 | 0.180 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 6.603564e-01 | 0.180 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 6.653838e-01 | 0.177 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 6.658888e-01 | 0.177 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 6.680006e-01 | 0.175 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 6.680006e-01 | 0.175 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 6.715396e-01 | 0.173 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 6.728273e-01 | 0.172 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 6.728273e-01 | 0.172 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 6.753110e-01 | 0.170 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 6.753110e-01 | 0.170 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.753110e-01 | 0.170 | 0 | 0 |
| Melanin biosynthesis | R-HSA-5662702 | 6.753110e-01 | 0.170 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 6.753110e-01 | 0.170 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 6.753110e-01 | 0.170 | 0 | 0 |
| Synthesis of Ketone Bodies | R-HSA-77111 | 6.753110e-01 | 0.170 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 6.753110e-01 | 0.170 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 6.753110e-01 | 0.170 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 6.782914e-01 | 0.169 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 6.811062e-01 | 0.167 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 6.811062e-01 | 0.167 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 6.811062e-01 | 0.167 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 6.866883e-01 | 0.163 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 6.878295e-01 | 0.163 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 6.883207e-01 | 0.162 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 6.883207e-01 | 0.162 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 6.883207e-01 | 0.162 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 6.883207e-01 | 0.162 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 6.883207e-01 | 0.162 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 6.883207e-01 | 0.162 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 6.893328e-01 | 0.162 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 6.893328e-01 | 0.162 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 6.893328e-01 | 0.162 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 6.896081e-01 | 0.161 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 6.896081e-01 | 0.161 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.896081e-01 | 0.161 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 6.896081e-01 | 0.161 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 6.896081e-01 | 0.161 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 6.896081e-01 | 0.161 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 6.944662e-01 | 0.158 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 6.965277e-01 | 0.157 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 6.973992e-01 | 0.157 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 6.973992e-01 | 0.157 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 6.980914e-01 | 0.156 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 6.980914e-01 | 0.156 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 6.980914e-01 | 0.156 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 6.980914e-01 | 0.156 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 6.980914e-01 | 0.156 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 6.980914e-01 | 0.156 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 6.980914e-01 | 0.156 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.009980e-01 | 0.154 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 7.014479e-01 | 0.154 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 7.014479e-01 | 0.154 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 7.032764e-01 | 0.153 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.032764e-01 | 0.153 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 7.032764e-01 | 0.153 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 7.032764e-01 | 0.153 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 7.032764e-01 | 0.153 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 7.032764e-01 | 0.153 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 7.053058e-01 | 0.152 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 7.053058e-01 | 0.152 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 7.053058e-01 | 0.152 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 7.076069e-01 | 0.150 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 7.076069e-01 | 0.150 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 7.083140e-01 | 0.150 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 7.083140e-01 | 0.150 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 7.130535e-01 | 0.147 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.133309e-01 | 0.147 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 7.150645e-01 | 0.146 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 7.163436e-01 | 0.145 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 7.163436e-01 | 0.145 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 7.163436e-01 | 0.145 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 7.168708e-01 | 0.145 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 7.206431e-01 | 0.142 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 7.221522e-01 | 0.141 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 7.246634e-01 | 0.140 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 7.258866e-01 | 0.139 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 7.258866e-01 | 0.139 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 7.280757e-01 | 0.138 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 7.288361e-01 | 0.137 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.288361e-01 | 0.137 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.288361e-01 | 0.137 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 7.288361e-01 | 0.137 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 7.288361e-01 | 0.137 | 0 | 0 |
| Ketone body metabolism | R-HSA-74182 | 7.288361e-01 | 0.137 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 7.291372e-01 | 0.137 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 7.301657e-01 | 0.137 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 7.346583e-01 | 0.134 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 7.402595e-01 | 0.131 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 7.407792e-01 | 0.130 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 7.407792e-01 | 0.130 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 7.407792e-01 | 0.130 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 7.407792e-01 | 0.130 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 7.407792e-01 | 0.130 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.407792e-01 | 0.130 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 7.407792e-01 | 0.130 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 7.409163e-01 | 0.130 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 7.424744e-01 | 0.129 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 7.424744e-01 | 0.129 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 7.431899e-01 | 0.129 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 7.431899e-01 | 0.129 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 7.431899e-01 | 0.129 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 7.463675e-01 | 0.127 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 7.470938e-01 | 0.127 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 7.499122e-01 | 0.125 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 7.509265e-01 | 0.124 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 7.514855e-01 | 0.124 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 7.514855e-01 | 0.124 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 7.514855e-01 | 0.124 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 7.514855e-01 | 0.124 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 7.521969e-01 | 0.124 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 7.521969e-01 | 0.124 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 7.521969e-01 | 0.124 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 7.521969e-01 | 0.124 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 7.521969e-01 | 0.124 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 7.521969e-01 | 0.124 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 7.521969e-01 | 0.124 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 7.521969e-01 | 0.124 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.521969e-01 | 0.124 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 7.521969e-01 | 0.124 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 7.531581e-01 | 0.123 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 7.562601e-01 | 0.121 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 7.591101e-01 | 0.120 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 7.595494e-01 | 0.119 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 7.595494e-01 | 0.119 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 7.595494e-01 | 0.119 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 7.595494e-01 | 0.119 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 7.631124e-01 | 0.117 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.631124e-01 | 0.117 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 7.631124e-01 | 0.117 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 7.631124e-01 | 0.117 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 7.631124e-01 | 0.117 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 7.631124e-01 | 0.117 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 7.631124e-01 | 0.117 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 7.631124e-01 | 0.117 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 7.673858e-01 | 0.115 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 7.673858e-01 | 0.115 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 7.686220e-01 | 0.114 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 7.735477e-01 | 0.112 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 7.735477e-01 | 0.112 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 7.735477e-01 | 0.112 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 7.735477e-01 | 0.112 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 7.735477e-01 | 0.112 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 7.735477e-01 | 0.112 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 7.749991e-01 | 0.111 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 7.749991e-01 | 0.111 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 7.749991e-01 | 0.111 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 7.758157e-01 | 0.110 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 7.758157e-01 | 0.110 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 7.799820e-01 | 0.108 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 7.818090e-01 | 0.107 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 7.818090e-01 | 0.107 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 7.818090e-01 | 0.107 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 7.823938e-01 | 0.107 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 7.823938e-01 | 0.107 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 7.823938e-01 | 0.107 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 7.831617e-01 | 0.106 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 7.835239e-01 | 0.106 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 7.835239e-01 | 0.106 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 7.835239e-01 | 0.106 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 7.835239e-01 | 0.106 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 7.835239e-01 | 0.106 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.872108e-01 | 0.104 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 7.895743e-01 | 0.103 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.895743e-01 | 0.103 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 7.895743e-01 | 0.103 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 7.930613e-01 | 0.101 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.930613e-01 | 0.101 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 7.930613e-01 | 0.101 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 7.930613e-01 | 0.101 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 7.930613e-01 | 0.101 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 7.930613e-01 | 0.101 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 7.930613e-01 | 0.101 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 7.940652e-01 | 0.100 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 7.940652e-01 | 0.100 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 7.965452e-01 | 0.099 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 7.965452e-01 | 0.099 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 7.965452e-01 | 0.099 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 8.021789e-01 | 0.096 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.021789e-01 | 0.096 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 8.021789e-01 | 0.096 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.021789e-01 | 0.096 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 8.021789e-01 | 0.096 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.021825e-01 | 0.096 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 8.033109e-01 | 0.095 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 8.077568e-01 | 0.093 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 8.108954e-01 | 0.091 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.108954e-01 | 0.091 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 8.108954e-01 | 0.091 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 8.108954e-01 | 0.091 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.108954e-01 | 0.091 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 8.162452e-01 | 0.088 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 8.162452e-01 | 0.088 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 8.162452e-01 | 0.088 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 8.162452e-01 | 0.088 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 8.162452e-01 | 0.088 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 8.162452e-01 | 0.088 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 8.164013e-01 | 0.088 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 8.164547e-01 | 0.088 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 8.192283e-01 | 0.087 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 8.192283e-01 | 0.087 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 8.192283e-01 | 0.087 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 8.217186e-01 | 0.085 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 8.224227e-01 | 0.085 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 8.271946e-01 | 0.082 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 8.271946e-01 | 0.082 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 8.271946e-01 | 0.082 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 8.271946e-01 | 0.082 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.271946e-01 | 0.082 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 8.271946e-01 | 0.082 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 8.271946e-01 | 0.082 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 8.284132e-01 | 0.082 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 8.311358e-01 | 0.080 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 8.348102e-01 | 0.078 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.348102e-01 | 0.078 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 8.348102e-01 | 0.078 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.348102e-01 | 0.078 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.348102e-01 | 0.078 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.367438e-01 | 0.077 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.377159e-01 | 0.077 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 8.398510e-01 | 0.076 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 8.415039e-01 | 0.075 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 8.415039e-01 | 0.075 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 8.420906e-01 | 0.075 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 8.420906e-01 | 0.075 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.420906e-01 | 0.075 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.420906e-01 | 0.075 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 8.420906e-01 | 0.075 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 8.420906e-01 | 0.075 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 8.420906e-01 | 0.075 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.420906e-01 | 0.075 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 8.453071e-01 | 0.073 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 8.453071e-01 | 0.073 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 8.474501e-01 | 0.072 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.478406e-01 | 0.072 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 8.490506e-01 | 0.071 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 8.490506e-01 | 0.071 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.490506e-01 | 0.071 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.490506e-01 | 0.071 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 8.490506e-01 | 0.071 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 8.490506e-01 | 0.071 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.517698e-01 | 0.070 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 8.551236e-01 | 0.068 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.557042e-01 | 0.068 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 8.557156e-01 | 0.068 | 0 | 0 |
| Translation | R-HSA-72766 | 8.587333e-01 | 0.066 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 8.593610e-01 | 0.066 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 8.606766e-01 | 0.065 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 8.620650e-01 | 0.064 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 8.620650e-01 | 0.064 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 8.620650e-01 | 0.064 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 8.620650e-01 | 0.064 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 8.620650e-01 | 0.064 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 8.635885e-01 | 0.064 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 8.654810e-01 | 0.063 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 8.654810e-01 | 0.063 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 8.676104e-01 | 0.062 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 8.681457e-01 | 0.061 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.681457e-01 | 0.061 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 8.692965e-01 | 0.061 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.701331e-01 | 0.060 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 8.701331e-01 | 0.060 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 8.701331e-01 | 0.060 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 8.701331e-01 | 0.060 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 8.701331e-01 | 0.060 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 8.704221e-01 | 0.060 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 8.739587e-01 | 0.059 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 8.739587e-01 | 0.059 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 8.739587e-01 | 0.059 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 8.739587e-01 | 0.059 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 8.754304e-01 | 0.058 | 0 | 0 |
| Disease | R-HSA-1643685 | 8.757175e-01 | 0.058 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 8.777119e-01 | 0.057 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 8.795158e-01 | 0.056 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 8.795158e-01 | 0.056 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.795158e-01 | 0.056 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.795158e-01 | 0.056 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 8.795158e-01 | 0.056 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 8.795158e-01 | 0.056 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 8.795158e-01 | 0.056 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 8.828383e-01 | 0.054 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 8.832154e-01 | 0.054 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 8.832154e-01 | 0.054 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 8.848282e-01 | 0.053 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 8.848282e-01 | 0.053 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.848282e-01 | 0.053 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 8.848282e-01 | 0.053 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 8.872981e-01 | 0.052 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 8.872981e-01 | 0.052 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 8.872981e-01 | 0.052 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 8.899066e-01 | 0.051 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 8.899066e-01 | 0.051 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 8.899066e-01 | 0.051 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 8.899066e-01 | 0.051 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 8.899066e-01 | 0.051 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.899066e-01 | 0.051 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 8.899066e-01 | 0.051 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 8.912483e-01 | 0.050 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 8.932152e-01 | 0.049 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 8.932152e-01 | 0.049 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 8.947615e-01 | 0.048 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 8.947615e-01 | 0.048 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 8.965619e-01 | 0.047 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 8.987656e-01 | 0.046 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 8.996675e-01 | 0.046 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 9.018055e-01 | 0.045 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.023401e-01 | 0.045 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.038391e-01 | 0.044 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.038391e-01 | 0.044 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 9.038391e-01 | 0.044 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.038391e-01 | 0.044 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.057665e-01 | 0.043 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.072323e-01 | 0.042 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.080803e-01 | 0.042 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 9.086886e-01 | 0.042 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.091383e-01 | 0.041 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.116031e-01 | 0.040 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.121347e-01 | 0.040 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.121347e-01 | 0.040 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 9.122573e-01 | 0.040 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 9.123689e-01 | 0.040 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.127332e-01 | 0.040 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.152044e-01 | 0.038 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.160105e-01 | 0.038 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.160105e-01 | 0.038 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.171683e-01 | 0.038 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 9.185096e-01 | 0.037 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.197156e-01 | 0.036 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.197156e-01 | 0.036 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.232574e-01 | 0.035 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.245587e-01 | 0.034 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.256873e-01 | 0.034 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.257925e-01 | 0.033 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.266432e-01 | 0.033 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.269441e-01 | 0.033 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 9.269665e-01 | 0.033 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 9.286093e-01 | 0.032 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.292602e-01 | 0.032 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.295965e-01 | 0.032 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.295965e-01 | 0.032 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 9.305687e-01 | 0.031 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.317891e-01 | 0.031 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.324348e-01 | 0.030 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.324348e-01 | 0.030 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.328261e-01 | 0.030 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.359315e-01 | 0.029 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.369596e-01 | 0.028 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.369596e-01 | 0.028 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.369596e-01 | 0.028 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.387588e-01 | 0.027 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.392945e-01 | 0.027 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.417952e-01 | 0.026 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.435886e-01 | 0.025 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.440451e-01 | 0.025 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.440451e-01 | 0.025 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.456470e-01 | 0.024 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.476338e-01 | 0.023 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.486387e-01 | 0.023 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.497510e-01 | 0.022 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.529195e-01 | 0.021 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 9.532898e-01 | 0.021 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.532898e-01 | 0.021 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.532898e-01 | 0.021 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.532898e-01 | 0.021 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.532898e-01 | 0.021 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 9.532898e-01 | 0.021 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.535223e-01 | 0.021 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.545060e-01 | 0.020 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 9.549099e-01 | 0.020 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 9.549099e-01 | 0.020 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.563037e-01 | 0.019 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.567622e-01 | 0.019 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.581752e-01 | 0.019 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.610088e-01 | 0.017 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.622167e-01 | 0.017 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 9.646396e-01 | 0.016 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.659498e-01 | 0.015 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.685256e-01 | 0.014 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.702654e-01 | 0.013 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.702654e-01 | 0.013 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.715790e-01 | 0.013 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.728346e-01 | 0.012 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.728346e-01 | 0.012 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.734227e-01 | 0.012 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.734869e-01 | 0.012 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.740347e-01 | 0.011 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.740347e-01 | 0.011 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.751820e-01 | 0.011 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.797479e-01 | 0.009 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.802020e-01 | 0.009 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.802020e-01 | 0.009 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.812561e-01 | 0.008 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.819135e-01 | 0.008 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.822744e-01 | 0.008 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.842077e-01 | 0.007 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.849251e-01 | 0.007 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.861492e-01 | 0.006 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.872618e-01 | 0.006 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.874038e-01 | 0.006 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.897604e-01 | 0.004 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.899705e-01 | 0.004 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.900126e-01 | 0.004 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.905087e-01 | 0.004 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 9.909717e-01 | 0.004 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.916172e-01 | 0.004 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.926816e-01 | 0.003 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.928668e-01 | 0.003 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.934322e-01 | 0.003 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.946695e-01 | 0.002 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.950938e-01 | 0.002 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.951092e-01 | 0.002 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.954715e-01 | 0.002 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.956495e-01 | 0.002 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.961179e-01 | 0.002 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.969397e-01 | 0.001 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.981376e-01 | 0.001 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.984356e-01 | 0.001 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.985017e-01 | 0.001 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.989494e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.992744e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.993154e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.993363e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.997647e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999320e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.999453e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999527e-01 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 9.999568e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999880e-01 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.999920e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999955e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999962e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999987e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999988e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 3.642642e-13 | 12.439 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 4.778955e-12 | 11.321 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.994183e-11 | 10.399 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 8.043632e-11 | 10.095 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.539315e-10 | 9.813 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.574538e-10 | 9.589 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 3.459081e-10 | 9.461 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 8.048823e-10 | 9.094 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 7.691722e-10 | 9.114 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.313292e-09 | 8.882 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.313292e-09 | 8.882 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.313292e-09 | 8.882 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.313292e-09 | 8.882 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.807015e-09 | 8.743 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.090604e-09 | 8.680 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 5.060446e-09 | 8.296 | 0 | 0 |
| M Phase | R-HSA-68886 | 6.158588e-09 | 8.211 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 9.864603e-09 | 8.006 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 4.702430e-08 | 7.328 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 5.333821e-08 | 7.273 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 6.009570e-08 | 7.221 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 7.918305e-08 | 7.101 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 9.054375e-08 | 7.043 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.525402e-07 | 6.817 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.675770e-07 | 6.776 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 2.507908e-07 | 6.601 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.777863e-07 | 6.556 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 3.060276e-07 | 6.514 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 5.421473e-07 | 6.266 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.291774e-06 | 5.889 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.972201e-06 | 5.705 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.299015e-06 | 5.638 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.636522e-06 | 5.579 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 3.184795e-06 | 5.497 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 4.362659e-06 | 5.360 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 4.349585e-06 | 5.362 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 4.402612e-06 | 5.356 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 4.782081e-06 | 5.320 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 5.061288e-06 | 5.296 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 5.495210e-06 | 5.260 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 9.781915e-06 | 5.010 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 9.781915e-06 | 5.010 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.362424e-05 | 4.866 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.470913e-05 | 4.832 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.733496e-05 | 4.761 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.975603e-05 | 4.704 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.731127e-05 | 4.564 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 3.115034e-05 | 4.507 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 3.175419e-05 | 4.498 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 3.396979e-05 | 4.469 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.995347e-05 | 4.398 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 4.284013e-05 | 4.368 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 4.384390e-05 | 4.358 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 5.599333e-05 | 4.252 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 6.673558e-05 | 4.176 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 7.022879e-05 | 4.153 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 7.720725e-05 | 4.112 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 8.025231e-05 | 4.096 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.129560e-04 | 3.947 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.129560e-04 | 3.947 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.152431e-04 | 3.938 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.397758e-04 | 3.855 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.420841e-04 | 3.847 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.592958e-04 | 3.798 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.957509e-04 | 3.708 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.081205e-04 | 3.682 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.242705e-04 | 3.649 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.420659e-04 | 3.616 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 2.437404e-04 | 3.613 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 2.461273e-04 | 3.609 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.577411e-04 | 3.589 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.577743e-04 | 3.589 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.577743e-04 | 3.589 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.732541e-04 | 3.563 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.826282e-04 | 3.549 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.844507e-04 | 3.546 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 3.039150e-04 | 3.517 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.110769e-04 | 3.507 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 3.291131e-04 | 3.483 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 3.395622e-04 | 3.469 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 3.877234e-04 | 3.411 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.910697e-04 | 3.408 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 4.107520e-04 | 3.386 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 4.189970e-04 | 3.378 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 4.322301e-04 | 3.364 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 4.454198e-04 | 3.351 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 4.639260e-04 | 3.334 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 4.640533e-04 | 3.333 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 5.154593e-04 | 3.288 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 5.779702e-04 | 3.238 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 5.829046e-04 | 3.234 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 6.265991e-04 | 3.203 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 6.395362e-04 | 3.194 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 7.113942e-04 | 3.148 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 7.525424e-04 | 3.123 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 7.754596e-04 | 3.110 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 7.935804e-04 | 3.100 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 7.900280e-04 | 3.102 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 7.579232e-04 | 3.120 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 8.036480e-04 | 3.095 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 7.502970e-04 | 3.125 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 8.058739e-04 | 3.094 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 8.765240e-04 | 3.057 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 8.929127e-04 | 3.049 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 9.219430e-04 | 3.035 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 9.742693e-04 | 3.011 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.056478e-03 | 2.976 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 9.902468e-04 | 3.004 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.050546e-03 | 2.979 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.192259e-03 | 2.924 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.200811e-03 | 2.921 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.221469e-03 | 2.913 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 1.313902e-03 | 2.881 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.526660e-03 | 2.816 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.466319e-03 | 2.834 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.526660e-03 | 2.816 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.443747e-03 | 2.841 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.526660e-03 | 2.816 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.472900e-03 | 2.832 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.546996e-03 | 2.811 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.564025e-03 | 2.806 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.600878e-03 | 2.796 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.600878e-03 | 2.796 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.602623e-03 | 2.795 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.654700e-03 | 2.781 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.722456e-03 | 2.764 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 1.955264e-03 | 2.709 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.876871e-03 | 2.727 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.802746e-03 | 2.744 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 2.010355e-03 | 2.697 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 2.048014e-03 | 2.689 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 2.073144e-03 | 2.683 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 2.239466e-03 | 2.650 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.239466e-03 | 2.650 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 2.267460e-03 | 2.644 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.307468e-03 | 2.637 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 2.307468e-03 | 2.637 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 2.414492e-03 | 2.617 | 0 | 0 |
| RSK activation | R-HSA-444257 | 2.913353e-03 | 2.536 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.702435e-03 | 2.568 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.934431e-03 | 2.532 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.706113e-03 | 2.568 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.674279e-03 | 2.573 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.913353e-03 | 2.536 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.297011e-03 | 2.482 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 3.418148e-03 | 2.466 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 3.534919e-03 | 2.452 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 3.534919e-03 | 2.452 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 3.587479e-03 | 2.445 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 3.645431e-03 | 2.438 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 3.741029e-03 | 2.427 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 3.821261e-03 | 2.418 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 3.821261e-03 | 2.418 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.953635e-03 | 2.403 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 3.997460e-03 | 2.398 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 4.096461e-03 | 2.388 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 4.104129e-03 | 2.387 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 4.104129e-03 | 2.387 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 4.443980e-03 | 2.352 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 4.724772e-03 | 2.326 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 4.368156e-03 | 2.360 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 4.584820e-03 | 2.339 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 4.794804e-03 | 2.319 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 4.926048e-03 | 2.308 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 4.927800e-03 | 2.307 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 5.012787e-03 | 2.300 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 5.056908e-03 | 2.296 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 5.131366e-03 | 2.290 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 5.237014e-03 | 2.281 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 5.237014e-03 | 2.281 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 5.617399e-03 | 2.250 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 5.663939e-03 | 2.247 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 5.701209e-03 | 2.244 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 5.800377e-03 | 2.237 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 6.270791e-03 | 2.203 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 6.561901e-03 | 2.183 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 6.944642e-03 | 2.158 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 7.019688e-03 | 2.154 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 7.718686e-03 | 2.112 | 0 | 0 |
| Protein folding | R-HSA-391251 | 8.815253e-03 | 2.055 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 7.839981e-03 | 2.106 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 8.823771e-03 | 2.054 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 7.811756e-03 | 2.107 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 8.966991e-03 | 2.047 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 9.007528e-03 | 2.045 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 9.007528e-03 | 2.045 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 9.007528e-03 | 2.045 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.185672e-03 | 2.037 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 9.340138e-03 | 2.030 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.005186e-02 | 1.998 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.063610e-02 | 1.973 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.063610e-02 | 1.973 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.063610e-02 | 1.973 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.090493e-02 | 1.962 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 1.115382e-02 | 1.953 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.278007e-02 | 1.893 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.278007e-02 | 1.893 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.180491e-02 | 1.928 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.238584e-02 | 1.907 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 1.115382e-02 | 1.953 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.178746e-02 | 1.929 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 1.234291e-02 | 1.909 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.313481e-02 | 1.882 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.313481e-02 | 1.882 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.405594e-02 | 1.852 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.405594e-02 | 1.852 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.405594e-02 | 1.852 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.483934e-02 | 1.829 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.485369e-02 | 1.828 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 1.524243e-02 | 1.817 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 1.525428e-02 | 1.817 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.525428e-02 | 1.817 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 1.525428e-02 | 1.817 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.915913e-02 | 1.718 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.915913e-02 | 1.718 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.915913e-02 | 1.718 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.915913e-02 | 1.718 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.915913e-02 | 1.718 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.915913e-02 | 1.718 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.915913e-02 | 1.718 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.915913e-02 | 1.718 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.915913e-02 | 1.718 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.915913e-02 | 1.718 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.915913e-02 | 1.718 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.629640e-02 | 1.788 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.665639e-02 | 1.778 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.817566e-02 | 1.741 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.842685e-02 | 1.735 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.622260e-02 | 1.790 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.629640e-02 | 1.788 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.626596e-02 | 1.789 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.776605e-02 | 1.750 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.816320e-02 | 1.741 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.816320e-02 | 1.741 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.776605e-02 | 1.750 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.830942e-02 | 1.737 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.816320e-02 | 1.741 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.973511e-02 | 1.705 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 1.981757e-02 | 1.703 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.087945e-02 | 1.680 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.141746e-02 | 1.669 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 2.141746e-02 | 1.669 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.209243e-02 | 1.656 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 2.211177e-02 | 1.655 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 2.211177e-02 | 1.655 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.216965e-02 | 1.654 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.216965e-02 | 1.654 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.216965e-02 | 1.654 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 2.250877e-02 | 1.648 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.253221e-02 | 1.647 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 2.395516e-02 | 1.621 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 2.505370e-02 | 1.601 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 2.892930e-02 | 1.539 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.609648e-02 | 1.583 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.579569e-02 | 1.588 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 2.558144e-02 | 1.592 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 2.558144e-02 | 1.592 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 2.785168e-02 | 1.555 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 3.025478e-02 | 1.519 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.943531e-02 | 1.531 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.943531e-02 | 1.531 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.904214e-02 | 1.537 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.904214e-02 | 1.537 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.988338e-02 | 1.525 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 3.025618e-02 | 1.519 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.556557e-02 | 1.592 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 2.916296e-02 | 1.535 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.609648e-02 | 1.583 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.984999e-02 | 1.525 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.562584e-02 | 1.591 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.512386e-02 | 1.600 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.729589e-02 | 1.564 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 2.609648e-02 | 1.583 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 2.609648e-02 | 1.583 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.579569e-02 | 1.588 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 3.136584e-02 | 1.504 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.025478e-02 | 1.519 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 2.609648e-02 | 1.583 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.579569e-02 | 1.588 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 2.682238e-02 | 1.572 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 3.136584e-02 | 1.504 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.750432e-02 | 1.561 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.750432e-02 | 1.561 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 3.086618e-02 | 1.511 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 3.144216e-02 | 1.502 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 3.144216e-02 | 1.502 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.151694e-02 | 1.501 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 3.151694e-02 | 1.501 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.194583e-02 | 1.496 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.194583e-02 | 1.496 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 3.329400e-02 | 1.478 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 3.340382e-02 | 1.476 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 3.354218e-02 | 1.474 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 3.354218e-02 | 1.474 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 3.354218e-02 | 1.474 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 3.425987e-02 | 1.465 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 3.425987e-02 | 1.465 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.510505e-02 | 1.455 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.510505e-02 | 1.455 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 3.654314e-02 | 1.437 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 3.663156e-02 | 1.436 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 3.720798e-02 | 1.429 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 3.836113e-02 | 1.416 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 3.842049e-02 | 1.415 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.897024e-02 | 1.409 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 3.902815e-02 | 1.409 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 3.956945e-02 | 1.403 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.975121e-02 | 1.401 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 4.026338e-02 | 1.395 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 4.026338e-02 | 1.395 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.026338e-02 | 1.395 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.026338e-02 | 1.395 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 5.112321e-02 | 1.291 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 5.297632e-02 | 1.276 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 5.297632e-02 | 1.276 | 0 | 0 |
| IRS activation | R-HSA-74713 | 5.297632e-02 | 1.276 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 5.297632e-02 | 1.276 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 5.297632e-02 | 1.276 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 5.319569e-02 | 1.274 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 5.319569e-02 | 1.274 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 5.319569e-02 | 1.274 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 4.964301e-02 | 1.304 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.124889e-02 | 1.385 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 4.435432e-02 | 1.353 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 4.435432e-02 | 1.353 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 5.100644e-02 | 1.292 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.455590e-02 | 1.263 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 5.455590e-02 | 1.263 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.000679e-02 | 1.301 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 4.301109e-02 | 1.366 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.733358e-02 | 1.325 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 4.124889e-02 | 1.385 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 5.455590e-02 | 1.263 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 4.303577e-02 | 1.366 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 4.964301e-02 | 1.304 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.435432e-02 | 1.353 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 5.297632e-02 | 1.276 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 4.346679e-02 | 1.362 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 4.724616e-02 | 1.326 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 4.550893e-02 | 1.342 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 5.454907e-02 | 1.263 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 4.760633e-02 | 1.322 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 5.098546e-02 | 1.293 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 4.964301e-02 | 1.304 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 4.303577e-02 | 1.366 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 4.938155e-02 | 1.306 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 4.550893e-02 | 1.342 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 4.303577e-02 | 1.366 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 4.698651e-02 | 1.328 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 4.177989e-02 | 1.379 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 4.415600e-02 | 1.355 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 4.352630e-02 | 1.361 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 5.417369e-02 | 1.266 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 5.544017e-02 | 1.256 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 5.548728e-02 | 1.256 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 5.548728e-02 | 1.256 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 5.548728e-02 | 1.256 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 5.641709e-02 | 1.249 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 5.646003e-02 | 1.248 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 5.646003e-02 | 1.248 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 5.672353e-02 | 1.246 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 5.672353e-02 | 1.246 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 5.689120e-02 | 1.245 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 5.932220e-02 | 1.227 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.980910e-02 | 1.223 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.980910e-02 | 1.223 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.000302e-02 | 1.222 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 6.146204e-02 | 1.211 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 6.146204e-02 | 1.211 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 6.146204e-02 | 1.211 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 6.153944e-02 | 1.211 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 6.168551e-02 | 1.210 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 6.168551e-02 | 1.210 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 6.179131e-02 | 1.209 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 6.179131e-02 | 1.209 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 6.210686e-02 | 1.207 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 6.210686e-02 | 1.207 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 6.316500e-02 | 1.200 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 6.316500e-02 | 1.200 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 6.332676e-02 | 1.198 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 6.332676e-02 | 1.198 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 6.393284e-02 | 1.194 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 6.710672e-02 | 1.173 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 6.710672e-02 | 1.173 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 6.823309e-02 | 1.166 | 0 | 0 |
| Kinesins | R-HSA-983189 | 7.026468e-02 | 1.153 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 7.028649e-02 | 1.153 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 7.028649e-02 | 1.153 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 7.074127e-02 | 1.150 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 7.082070e-02 | 1.150 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 7.169493e-02 | 1.145 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 7.219423e-02 | 1.141 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 7.253712e-02 | 1.139 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 7.352585e-02 | 1.134 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 7.406395e-02 | 1.130 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 7.457183e-02 | 1.127 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 7.463885e-02 | 1.127 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 7.512418e-02 | 1.124 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 7.512418e-02 | 1.124 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 9.963578e-02 | 1.002 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 9.963578e-02 | 1.002 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 9.963578e-02 | 1.002 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 9.963578e-02 | 1.002 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 9.963578e-02 | 1.002 | 0 | 0 |
| SARS-CoV-1 targets PDZ proteins in cell-cell junction | R-HSA-9692912 | 9.963578e-02 | 1.002 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 9.963578e-02 | 1.002 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 9.963578e-02 | 1.002 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 8.187153e-02 | 1.087 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 9.775363e-02 | 1.010 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 9.775363e-02 | 1.010 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 9.775363e-02 | 1.010 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 9.775363e-02 | 1.010 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 1.144124e-01 | 0.942 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.144124e-01 | 0.942 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.144124e-01 | 0.942 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 7.964529e-02 | 1.099 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 9.986222e-02 | 1.001 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.106652e-01 | 0.956 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.106652e-01 | 0.956 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 8.990795e-02 | 1.046 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 9.778369e-02 | 1.010 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 9.778369e-02 | 1.010 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 8.452062e-02 | 1.073 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 1.040732e-01 | 0.983 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.040732e-01 | 0.983 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 9.923896e-02 | 1.003 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.051275e-01 | 0.978 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.111934e-01 | 0.954 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.089421e-01 | 0.963 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 8.990795e-02 | 1.046 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 9.309638e-02 | 1.031 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.144540e-01 | 0.941 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 1.144124e-01 | 0.942 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 7.964529e-02 | 1.099 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 8.709388e-02 | 1.060 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 7.866353e-02 | 1.104 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 1.110469e-01 | 0.954 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.050813e-01 | 0.978 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 9.986222e-02 | 1.001 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 7.879013e-02 | 1.104 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 8.235180e-02 | 1.084 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 8.709388e-02 | 1.060 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 8.452062e-02 | 1.073 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 9.963578e-02 | 1.002 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 1.059692e-01 | 0.975 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 1.144540e-01 | 0.941 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.040732e-01 | 0.983 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.040732e-01 | 0.983 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 9.775363e-02 | 1.010 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 8.266197e-02 | 1.083 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.085587e-01 | 0.964 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 7.903102e-02 | 1.102 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 8.947697e-02 | 1.048 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 1.144124e-01 | 0.942 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 7.964529e-02 | 1.099 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 8.990795e-02 | 1.046 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 8.880377e-02 | 1.052 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 9.683305e-02 | 1.014 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 9.775363e-02 | 1.010 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 9.775363e-02 | 1.010 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 7.750590e-02 | 1.111 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 9.188329e-02 | 1.037 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 9.113006e-02 | 1.040 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.144124e-01 | 0.942 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.040128e-01 | 0.983 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 1.106652e-01 | 0.956 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 1.144540e-01 | 0.941 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.213168e-02 | 1.036 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.174337e-01 | 0.930 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.200855e-01 | 0.921 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 1.218930e-01 | 0.914 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.223756e-01 | 0.912 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.223756e-01 | 0.912 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.232267e-01 | 0.909 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.232267e-01 | 0.909 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.238451e-01 | 0.907 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.238451e-01 | 0.907 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.238451e-01 | 0.907 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.247626e-01 | 0.904 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.256477e-01 | 0.901 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.258693e-01 | 0.900 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.283155e-01 | 0.892 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.288054e-01 | 0.890 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 1.291421e-01 | 0.889 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.294290e-01 | 0.888 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.304242e-01 | 0.885 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.315753e-01 | 0.881 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.317271e-01 | 0.880 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.317271e-01 | 0.880 | 0 | 0 |
| Hypusine synthesis from eIF5A-lysine | R-HSA-204626 | 1.317271e-01 | 0.880 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 1.317271e-01 | 0.880 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.317271e-01 | 0.880 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.317271e-01 | 0.880 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 1.317271e-01 | 0.880 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 1.317271e-01 | 0.880 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 1.317271e-01 | 0.880 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.317271e-01 | 0.880 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.317271e-01 | 0.880 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 1.317271e-01 | 0.880 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 1.317271e-01 | 0.880 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.322756e-01 | 0.879 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 1.322756e-01 | 0.879 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.322756e-01 | 0.879 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 1.335162e-01 | 0.874 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.344681e-01 | 0.871 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.347018e-01 | 0.871 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 1.456709e-01 | 0.837 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 1.456709e-01 | 0.837 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 1.456709e-01 | 0.837 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 1.456709e-01 | 0.837 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 1.456709e-01 | 0.837 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 1.456709e-01 | 0.837 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 1.456709e-01 | 0.837 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 1.893548e-01 | 0.723 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 1.893548e-01 | 0.723 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 1.893548e-01 | 0.723 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 2.308077e-01 | 0.637 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 2.308077e-01 | 0.637 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 2.308077e-01 | 0.637 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 2.308077e-01 | 0.637 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 2.308077e-01 | 0.637 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 2.308077e-01 | 0.637 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 2.701431e-01 | 0.568 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.701431e-01 | 0.568 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.701431e-01 | 0.568 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 2.701431e-01 | 0.568 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 2.701431e-01 | 0.568 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 1.495875e-01 | 0.825 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.495875e-01 | 0.825 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.495875e-01 | 0.825 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.495875e-01 | 0.825 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 1.495875e-01 | 0.825 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 1.865502e-01 | 0.729 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.865502e-01 | 0.729 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 1.865502e-01 | 0.729 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 1.865502e-01 | 0.729 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 2.054769e-01 | 0.687 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 2.054769e-01 | 0.687 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 2.054769e-01 | 0.687 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 2.054769e-01 | 0.687 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 2.245963e-01 | 0.649 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.578301e-01 | 0.802 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.578301e-01 | 0.802 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 1.578301e-01 | 0.802 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 2.438395e-01 | 0.613 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 2.438395e-01 | 0.613 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 1.833702e-01 | 0.737 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 2.631438e-01 | 0.580 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 2.631438e-01 | 0.580 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 1.965273e-01 | 0.707 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 1.965273e-01 | 0.707 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.511522e-01 | 0.821 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.609539e-01 | 0.793 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 1.709802e-01 | 0.767 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.812174e-01 | 0.742 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.372098e-01 | 0.625 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.572896e-01 | 0.803 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 2.510849e-01 | 0.600 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.511288e-01 | 0.821 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 2.239978e-01 | 0.650 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 2.350813e-01 | 0.629 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 2.350813e-01 | 0.629 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 2.350813e-01 | 0.629 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 2.099931e-01 | 0.678 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 2.576177e-01 | 0.589 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 2.576177e-01 | 0.589 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 2.576177e-01 | 0.589 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.658935e-01 | 0.780 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.506882e-01 | 0.601 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.455051e-01 | 0.837 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.865502e-01 | 0.729 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.865502e-01 | 0.729 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 1.976752e-01 | 0.704 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 1.495875e-01 | 0.825 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 1.865502e-01 | 0.729 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.495875e-01 | 0.825 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 1.495875e-01 | 0.825 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.495875e-01 | 0.825 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 1.812174e-01 | 0.742 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 2.701431e-01 | 0.568 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 2.054769e-01 | 0.687 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.440702e-01 | 0.841 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.126034e-01 | 0.672 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 2.054769e-01 | 0.687 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 2.054769e-01 | 0.687 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 2.462925e-01 | 0.609 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 2.576177e-01 | 0.589 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.372098e-01 | 0.625 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.415230e-01 | 0.849 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.372098e-01 | 0.625 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.045048e-01 | 0.689 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 1.490908e-01 | 0.827 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 2.022691e-01 | 0.694 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.110403e-01 | 0.676 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.054769e-01 | 0.687 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.832275e-01 | 0.737 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.247434e-01 | 0.648 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 1.860230e-01 | 0.730 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.962003e-01 | 0.707 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 2.510849e-01 | 0.600 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.667672e-01 | 0.778 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 1.687921e-01 | 0.773 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.962003e-01 | 0.707 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.568131e-01 | 0.805 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 1.893548e-01 | 0.723 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 1.893548e-01 | 0.723 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 2.308077e-01 | 0.637 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 2.701431e-01 | 0.568 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.678925e-01 | 0.775 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.865502e-01 | 0.729 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 1.578301e-01 | 0.802 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.631438e-01 | 0.580 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 1.965273e-01 | 0.707 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.099046e-01 | 0.678 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.099046e-01 | 0.678 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 2.372098e-01 | 0.625 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.742200e-01 | 0.759 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 2.650745e-01 | 0.577 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.583388e-01 | 0.800 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 2.208755e-01 | 0.656 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.773509e-01 | 0.557 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 2.101532e-01 | 0.677 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 2.576177e-01 | 0.589 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.838236e-01 | 0.736 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 2.438395e-01 | 0.613 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.812174e-01 | 0.742 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.674914e-01 | 0.573 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.704615e-01 | 0.768 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 2.631438e-01 | 0.580 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 2.054769e-01 | 0.687 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.507935e-01 | 0.822 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.302575e-01 | 0.638 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.368853e-01 | 0.625 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 1.455051e-01 | 0.837 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 1.455051e-01 | 0.837 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 2.723066e-01 | 0.565 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 2.631438e-01 | 0.580 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.609539e-01 | 0.793 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.572896e-01 | 0.803 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.461997e-01 | 0.609 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 2.275805e-01 | 0.643 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 2.676403e-01 | 0.572 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.635271e-01 | 0.579 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 2.676403e-01 | 0.572 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 1.901434e-01 | 0.721 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 2.350813e-01 | 0.629 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 2.350813e-01 | 0.629 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.655764e-01 | 0.781 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 2.248185e-01 | 0.648 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 2.701431e-01 | 0.568 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.495875e-01 | 0.825 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 2.245963e-01 | 0.649 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 2.350813e-01 | 0.629 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.700827e-01 | 0.769 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 2.178511e-01 | 0.662 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 2.178511e-01 | 0.662 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 2.178511e-01 | 0.662 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 2.664719e-01 | 0.574 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 2.148471e-01 | 0.668 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 2.341589e-01 | 0.630 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 2.510849e-01 | 0.600 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.407695e-01 | 0.851 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.640757e-01 | 0.785 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.234743e-01 | 0.651 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.234743e-01 | 0.651 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.462925e-01 | 0.609 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.352017e-01 | 0.629 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 2.292203e-01 | 0.640 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 1.841695e-01 | 0.735 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.511288e-01 | 0.821 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.665171e-01 | 0.779 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 2.387598e-01 | 0.622 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 2.308077e-01 | 0.637 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 1.495875e-01 | 0.825 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 2.245963e-01 | 0.649 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 2.631438e-01 | 0.580 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 2.239978e-01 | 0.650 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 2.462925e-01 | 0.609 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.561289e-01 | 0.807 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.549213e-01 | 0.594 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 1.556179e-01 | 0.808 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.908619e-01 | 0.719 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 2.631438e-01 | 0.580 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 2.054769e-01 | 0.687 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.966634e-01 | 0.706 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 1.572896e-01 | 0.803 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 2.382379e-01 | 0.623 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.833702e-01 | 0.737 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.865502e-01 | 0.729 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.631438e-01 | 0.580 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.631438e-01 | 0.580 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.130558e-01 | 0.672 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 2.292203e-01 | 0.640 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.234743e-01 | 0.651 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.664994e-01 | 0.779 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 2.172793e-01 | 0.663 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.827725e-01 | 0.738 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 1.583388e-01 | 0.800 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.612042e-01 | 0.793 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 2.245963e-01 | 0.649 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.438395e-01 | 0.613 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 2.234743e-01 | 0.651 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.239978e-01 | 0.650 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.784233e-01 | 0.749 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 1.490908e-01 | 0.827 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.883121e-01 | 0.725 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 1.916516e-01 | 0.717 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.126352e-01 | 0.672 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 2.438395e-01 | 0.613 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.916516e-01 | 0.717 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.578301e-01 | 0.802 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.656954e-01 | 0.781 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.242370e-01 | 0.649 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.495875e-01 | 0.825 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 2.245963e-01 | 0.649 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 2.773509e-01 | 0.557 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 1.965273e-01 | 0.707 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 2.791544e-01 | 0.554 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 2.791544e-01 | 0.554 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 2.805567e-01 | 0.552 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 2.805567e-01 | 0.552 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 2.805567e-01 | 0.552 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 2.805567e-01 | 0.552 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 2.824529e-01 | 0.549 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.824529e-01 | 0.549 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 2.824529e-01 | 0.549 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 2.824529e-01 | 0.549 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 2.824529e-01 | 0.549 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 2.824529e-01 | 0.549 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 2.883907e-01 | 0.540 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 2.883907e-01 | 0.540 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.906287e-01 | 0.537 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 2.921442e-01 | 0.534 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 2.921442e-01 | 0.534 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.921442e-01 | 0.534 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.921442e-01 | 0.534 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 2.933012e-01 | 0.533 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 2.933012e-01 | 0.533 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 2.933012e-01 | 0.533 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 2.991423e-01 | 0.524 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 2.995515e-01 | 0.524 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 3.017158e-01 | 0.520 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 3.017158e-01 | 0.520 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 3.017158e-01 | 0.520 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 3.017158e-01 | 0.520 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 3.017158e-01 | 0.520 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 3.017158e-01 | 0.520 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 3.017158e-01 | 0.520 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 3.019106e-01 | 0.520 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 3.037932e-01 | 0.517 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 3.037932e-01 | 0.517 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 3.037932e-01 | 0.517 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 3.037932e-01 | 0.517 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 3.037932e-01 | 0.517 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 3.051368e-01 | 0.516 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 3.074693e-01 | 0.512 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 3.074693e-01 | 0.512 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 3.074693e-01 | 0.512 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 3.074693e-01 | 0.512 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 3.074693e-01 | 0.512 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 3.074693e-01 | 0.512 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 3.074693e-01 | 0.512 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 3.074693e-01 | 0.512 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 3.074693e-01 | 0.512 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 3.074693e-01 | 0.512 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 3.074693e-01 | 0.512 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 3.074802e-01 | 0.512 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 3.074802e-01 | 0.512 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 3.080597e-01 | 0.511 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 3.111627e-01 | 0.507 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 3.154914e-01 | 0.501 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 3.172185e-01 | 0.499 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 3.176304e-01 | 0.498 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 3.208868e-01 | 0.494 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 3.208868e-01 | 0.494 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 3.208868e-01 | 0.494 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 3.208868e-01 | 0.494 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 3.208868e-01 | 0.494 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 3.217079e-01 | 0.493 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 3.217079e-01 | 0.493 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 3.217079e-01 | 0.493 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 3.278207e-01 | 0.484 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.318819e-01 | 0.479 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 3.318819e-01 | 0.479 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 3.359262e-01 | 0.474 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 3.380432e-01 | 0.471 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 3.389868e-01 | 0.470 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 3.399250e-01 | 0.469 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 3.399250e-01 | 0.469 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 3.399250e-01 | 0.469 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 3.399250e-01 | 0.469 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 3.399250e-01 | 0.469 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 3.399250e-01 | 0.469 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 3.399250e-01 | 0.469 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 3.399250e-01 | 0.469 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 3.399250e-01 | 0.469 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 3.402421e-01 | 0.468 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 3.428887e-01 | 0.465 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 3.428887e-01 | 0.465 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 3.428887e-01 | 0.465 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 3.428887e-01 | 0.465 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 3.428887e-01 | 0.465 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 3.428887e-01 | 0.465 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 3.428887e-01 | 0.465 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 3.428887e-01 | 0.465 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 3.428887e-01 | 0.465 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 3.428887e-01 | 0.465 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 3.428887e-01 | 0.465 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 3.428887e-01 | 0.465 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 3.428887e-01 | 0.465 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 3.428887e-01 | 0.465 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 3.428887e-01 | 0.465 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.428887e-01 | 0.465 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 3.428887e-01 | 0.465 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 3.472398e-01 | 0.459 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 3.482903e-01 | 0.458 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 3.486289e-01 | 0.458 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 3.501284e-01 | 0.456 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 3.501284e-01 | 0.456 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 3.501284e-01 | 0.456 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 3.507609e-01 | 0.455 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 3.587939e-01 | 0.445 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 3.587939e-01 | 0.445 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 3.587939e-01 | 0.445 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 3.587939e-01 | 0.445 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 3.625375e-01 | 0.441 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 3.625375e-01 | 0.441 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 3.642965e-01 | 0.439 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 3.642965e-01 | 0.439 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.642965e-01 | 0.439 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 3.642965e-01 | 0.439 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 3.642965e-01 | 0.439 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 3.642965e-01 | 0.439 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 3.642965e-01 | 0.439 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 3.743061e-01 | 0.427 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 3.743061e-01 | 0.427 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 3.764986e-01 | 0.424 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.764986e-01 | 0.424 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 3.764986e-01 | 0.424 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 3.764986e-01 | 0.424 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 3.764986e-01 | 0.424 | 0 | 0 |
| Metabolism of ingested MeSeO2H into MeSeH | R-HSA-5263617 | 3.764986e-01 | 0.424 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 3.764986e-01 | 0.424 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.764986e-01 | 0.424 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 3.764986e-01 | 0.424 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 3.764986e-01 | 0.424 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 3.764986e-01 | 0.424 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 3.764986e-01 | 0.424 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 3.764986e-01 | 0.424 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 3.764986e-01 | 0.424 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.764986e-01 | 0.424 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 3.764986e-01 | 0.424 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 3.764986e-01 | 0.424 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 3.774611e-01 | 0.423 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 3.774611e-01 | 0.423 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 3.784131e-01 | 0.422 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 3.784131e-01 | 0.422 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 3.784131e-01 | 0.422 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 3.824690e-01 | 0.417 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 3.860562e-01 | 0.413 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 3.893746e-01 | 0.410 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.903138e-01 | 0.409 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 3.924621e-01 | 0.406 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 3.924621e-01 | 0.406 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 3.924621e-01 | 0.406 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.924621e-01 | 0.406 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 3.958979e-01 | 0.402 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 3.958979e-01 | 0.402 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 3.958979e-01 | 0.402 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.977779e-01 | 0.400 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 3.981634e-01 | 0.400 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 3.996339e-01 | 0.398 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 3.996339e-01 | 0.398 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 4.020877e-01 | 0.396 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 4.064282e-01 | 0.391 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 4.064282e-01 | 0.391 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 4.077288e-01 | 0.390 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 4.077288e-01 | 0.390 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 4.083914e-01 | 0.389 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 4.083914e-01 | 0.389 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 4.083914e-01 | 0.389 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 4.083914e-01 | 0.389 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 4.083914e-01 | 0.389 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 4.083914e-01 | 0.389 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 4.083914e-01 | 0.389 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 4.083914e-01 | 0.389 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 4.083914e-01 | 0.389 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 4.083914e-01 | 0.389 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 4.083914e-01 | 0.389 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 4.083914e-01 | 0.389 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 4.083914e-01 | 0.389 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 4.083914e-01 | 0.389 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 4.083914e-01 | 0.389 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 4.091060e-01 | 0.388 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 4.098749e-01 | 0.387 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 4.140791e-01 | 0.383 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 4.140791e-01 | 0.383 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 4.140791e-01 | 0.383 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 4.140791e-01 | 0.383 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 4.187495e-01 | 0.378 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 4.202974e-01 | 0.376 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 4.210983e-01 | 0.376 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 4.230970e-01 | 0.374 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 4.275099e-01 | 0.369 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 4.319826e-01 | 0.365 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 4.319826e-01 | 0.365 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 4.319826e-01 | 0.365 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 4.319826e-01 | 0.365 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 4.319826e-01 | 0.365 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 4.330484e-01 | 0.363 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 4.340562e-01 | 0.362 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 4.340562e-01 | 0.362 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 4.340562e-01 | 0.362 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 4.340562e-01 | 0.362 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 4.340562e-01 | 0.362 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 4.340562e-01 | 0.362 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 4.386546e-01 | 0.358 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 4.386546e-01 | 0.358 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 4.386546e-01 | 0.358 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 4.386546e-01 | 0.358 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 4.386546e-01 | 0.358 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 4.386546e-01 | 0.358 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 4.386546e-01 | 0.358 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 4.386546e-01 | 0.358 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 4.386546e-01 | 0.358 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 4.386546e-01 | 0.358 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 4.386546e-01 | 0.358 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 4.386546e-01 | 0.358 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 4.441959e-01 | 0.352 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 4.476923e-01 | 0.349 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 4.476923e-01 | 0.349 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 4.476923e-01 | 0.349 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 4.476923e-01 | 0.349 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 4.482009e-01 | 0.349 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 4.495892e-01 | 0.347 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 4.505296e-01 | 0.346 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 4.556404e-01 | 0.341 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 4.556404e-01 | 0.341 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 4.611943e-01 | 0.336 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 4.611943e-01 | 0.336 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 4.668826e-01 | 0.331 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 4.670053e-01 | 0.331 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 4.670053e-01 | 0.331 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 4.670053e-01 | 0.331 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 4.673715e-01 | 0.330 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 4.673715e-01 | 0.330 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 4.673715e-01 | 0.330 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 4.673715e-01 | 0.330 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 4.673715e-01 | 0.330 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 4.673715e-01 | 0.330 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 4.673715e-01 | 0.330 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 4.673715e-01 | 0.330 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 4.673715e-01 | 0.330 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 4.673715e-01 | 0.330 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 4.673715e-01 | 0.330 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 4.673715e-01 | 0.330 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 4.730531e-01 | 0.325 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 4.745517e-01 | 0.324 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 4.745517e-01 | 0.324 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 4.745517e-01 | 0.324 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 4.745517e-01 | 0.324 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 4.745517e-01 | 0.324 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 4.782834e-01 | 0.320 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 4.782834e-01 | 0.320 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 4.782834e-01 | 0.320 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 4.782834e-01 | 0.320 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 4.782834e-01 | 0.320 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 4.796496e-01 | 0.319 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 4.810565e-01 | 0.318 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 4.820476e-01 | 0.317 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 4.820476e-01 | 0.317 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 4.838487e-01 | 0.315 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 4.838487e-01 | 0.315 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 4.838487e-01 | 0.315 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 4.838487e-01 | 0.315 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 4.838487e-01 | 0.315 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 4.877546e-01 | 0.312 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 4.877546e-01 | 0.312 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 4.877546e-01 | 0.312 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 4.894679e-01 | 0.310 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 4.894679e-01 | 0.310 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 4.904117e-01 | 0.309 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 4.904117e-01 | 0.309 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 4.921026e-01 | 0.308 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 4.946209e-01 | 0.306 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 4.946209e-01 | 0.306 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.946209e-01 | 0.306 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 4.946209e-01 | 0.306 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 4.946209e-01 | 0.306 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 4.946209e-01 | 0.306 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 4.946209e-01 | 0.306 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 4.946209e-01 | 0.306 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 4.946209e-01 | 0.306 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 4.946209e-01 | 0.306 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 5.004757e-01 | 0.301 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 5.004757e-01 | 0.301 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 5.004757e-01 | 0.301 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 5.005526e-01 | 0.301 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 5.007941e-01 | 0.300 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 5.007941e-01 | 0.300 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 5.068972e-01 | 0.295 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 5.068972e-01 | 0.295 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.115314e-01 | 0.291 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.115314e-01 | 0.291 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 5.115314e-01 | 0.291 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 5.115314e-01 | 0.291 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 5.133101e-01 | 0.290 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 5.136623e-01 | 0.289 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 5.136623e-01 | 0.289 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 5.144709e-01 | 0.289 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 5.167540e-01 | 0.287 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 5.167540e-01 | 0.287 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 5.167540e-01 | 0.287 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 5.190840e-01 | 0.285 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 5.204779e-01 | 0.284 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 5.204779e-01 | 0.284 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 5.204779e-01 | 0.284 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 5.204779e-01 | 0.284 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 5.204779e-01 | 0.284 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 5.204779e-01 | 0.284 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 5.204779e-01 | 0.284 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 5.223988e-01 | 0.282 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.223988e-01 | 0.282 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 5.263516e-01 | 0.279 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 5.263516e-01 | 0.279 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 5.306099e-01 | 0.275 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 5.326757e-01 | 0.274 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 5.326757e-01 | 0.274 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 5.326757e-01 | 0.274 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 5.326757e-01 | 0.274 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 5.326757e-01 | 0.274 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 5.326757e-01 | 0.274 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 5.326757e-01 | 0.274 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 5.331495e-01 | 0.273 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 5.345034e-01 | 0.272 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 5.348955e-01 | 0.272 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 5.386882e-01 | 0.269 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 5.388555e-01 | 0.269 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 5.450134e-01 | 0.264 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 5.450134e-01 | 0.264 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 5.450134e-01 | 0.264 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 5.450134e-01 | 0.264 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 5.450134e-01 | 0.264 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 5.450134e-01 | 0.264 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 5.450134e-01 | 0.264 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 5.450134e-01 | 0.264 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 5.450134e-01 | 0.264 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 5.450134e-01 | 0.264 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 5.475725e-01 | 0.262 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.482348e-01 | 0.261 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 5.482348e-01 | 0.261 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 5.482348e-01 | 0.261 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 5.482348e-01 | 0.261 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 5.484458e-01 | 0.261 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 5.511680e-01 | 0.259 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 5.511680e-01 | 0.259 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 5.517114e-01 | 0.258 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 5.520056e-01 | 0.258 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 5.542820e-01 | 0.256 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 5.574007e-01 | 0.254 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 5.590195e-01 | 0.253 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 5.604524e-01 | 0.251 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 5.632838e-01 | 0.249 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 5.632838e-01 | 0.249 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 5.634265e-01 | 0.249 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 5.634265e-01 | 0.249 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 5.682949e-01 | 0.245 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 5.682949e-01 | 0.245 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 5.682949e-01 | 0.245 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 5.682949e-01 | 0.245 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 5.682949e-01 | 0.245 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 5.682949e-01 | 0.245 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 5.682949e-01 | 0.245 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 5.682949e-01 | 0.245 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.682949e-01 | 0.245 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 5.751983e-01 | 0.240 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 5.751983e-01 | 0.240 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 5.751983e-01 | 0.240 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 5.782478e-01 | 0.238 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 5.787942e-01 | 0.237 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 5.849958e-01 | 0.233 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 5.869076e-01 | 0.231 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 5.903864e-01 | 0.229 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 5.903864e-01 | 0.229 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.903864e-01 | 0.229 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 5.903864e-01 | 0.229 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 5.903864e-01 | 0.229 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 5.903864e-01 | 0.229 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 5.926969e-01 | 0.227 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 5.934592e-01 | 0.227 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 5.984080e-01 | 0.223 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 5.998246e-01 | 0.222 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 6.015044e-01 | 0.221 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 6.017340e-01 | 0.221 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 6.024519e-01 | 0.220 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 6.067729e-01 | 0.217 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 6.067729e-01 | 0.217 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 6.067729e-01 | 0.217 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 6.067729e-01 | 0.217 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 6.067729e-01 | 0.217 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 6.067729e-01 | 0.217 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 6.067729e-01 | 0.217 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 6.096967e-01 | 0.215 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 6.113348e-01 | 0.214 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 6.113487e-01 | 0.214 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 6.113487e-01 | 0.214 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 6.113487e-01 | 0.214 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 6.113487e-01 | 0.214 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 6.113487e-01 | 0.214 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 6.113487e-01 | 0.214 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 6.113487e-01 | 0.214 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 6.113487e-01 | 0.214 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 6.144460e-01 | 0.212 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 6.162415e-01 | 0.210 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 6.173332e-01 | 0.209 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 6.197248e-01 | 0.208 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 6.204763e-01 | 0.207 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 6.204763e-01 | 0.207 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 6.207713e-01 | 0.207 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 6.290730e-01 | 0.201 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 6.312395e-01 | 0.200 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 6.312395e-01 | 0.200 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 6.312395e-01 | 0.200 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 6.312395e-01 | 0.200 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 6.312395e-01 | 0.200 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 6.312395e-01 | 0.200 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 6.312395e-01 | 0.200 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 6.312395e-01 | 0.200 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 6.312395e-01 | 0.200 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 6.312395e-01 | 0.200 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 6.312395e-01 | 0.200 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 6.312395e-01 | 0.200 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 6.312395e-01 | 0.200 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 6.316299e-01 | 0.200 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 6.338083e-01 | 0.198 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 6.338083e-01 | 0.198 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 6.338083e-01 | 0.198 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 6.338083e-01 | 0.198 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 6.338083e-01 | 0.198 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 6.445376e-01 | 0.191 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 6.467710e-01 | 0.189 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 6.467710e-01 | 0.189 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 6.467710e-01 | 0.189 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 6.467710e-01 | 0.189 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 6.501134e-01 | 0.187 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 6.501134e-01 | 0.187 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 6.501134e-01 | 0.187 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 6.501134e-01 | 0.187 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 6.501134e-01 | 0.187 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 6.501134e-01 | 0.187 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 6.501134e-01 | 0.187 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 6.501134e-01 | 0.187 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 6.501134e-01 | 0.187 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 6.516308e-01 | 0.186 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 6.526937e-01 | 0.185 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 6.526937e-01 | 0.185 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 6.526937e-01 | 0.185 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 6.583054e-01 | 0.182 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 6.593673e-01 | 0.181 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 6.593673e-01 | 0.181 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 6.605436e-01 | 0.180 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 6.680224e-01 | 0.175 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 6.680224e-01 | 0.175 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.680224e-01 | 0.175 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 6.680224e-01 | 0.175 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 6.680224e-01 | 0.175 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 6.680224e-01 | 0.175 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 6.693007e-01 | 0.174 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 6.716007e-01 | 0.173 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 6.765365e-01 | 0.170 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 6.779014e-01 | 0.169 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 6.834753e-01 | 0.165 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 6.834753e-01 | 0.165 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 6.850157e-01 | 0.164 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.850157e-01 | 0.164 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 6.850157e-01 | 0.164 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.850157e-01 | 0.164 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 6.850157e-01 | 0.164 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 6.850157e-01 | 0.164 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 6.850157e-01 | 0.164 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 6.850157e-01 | 0.164 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 6.863450e-01 | 0.163 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 6.921929e-01 | 0.160 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 6.949959e-01 | 0.158 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 7.011402e-01 | 0.154 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 7.011402e-01 | 0.154 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 7.011402e-01 | 0.154 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 7.011402e-01 | 0.154 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 7.011402e-01 | 0.154 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 7.011402e-01 | 0.154 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 7.043215e-01 | 0.152 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 7.061675e-01 | 0.151 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 7.106327e-01 | 0.148 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 7.120945e-01 | 0.147 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 7.164402e-01 | 0.145 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 7.164402e-01 | 0.145 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 7.164402e-01 | 0.145 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 7.164402e-01 | 0.145 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 7.164402e-01 | 0.145 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 7.164402e-01 | 0.145 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 7.164402e-01 | 0.145 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 7.164402e-01 | 0.145 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 7.164402e-01 | 0.145 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 7.169957e-01 | 0.144 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 7.169957e-01 | 0.144 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 7.169957e-01 | 0.144 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 7.205114e-01 | 0.142 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 7.239097e-01 | 0.140 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 7.274863e-01 | 0.138 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 7.309577e-01 | 0.136 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 7.309577e-01 | 0.136 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 7.309577e-01 | 0.136 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 7.309577e-01 | 0.136 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 7.309577e-01 | 0.136 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 7.309577e-01 | 0.136 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 7.309577e-01 | 0.136 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 7.309577e-01 | 0.136 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 7.309577e-01 | 0.136 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 7.309577e-01 | 0.136 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 7.309577e-01 | 0.136 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 7.337049e-01 | 0.134 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 7.380122e-01 | 0.132 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 7.425168e-01 | 0.129 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 7.425168e-01 | 0.129 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 7.425168e-01 | 0.129 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 7.429846e-01 | 0.129 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 7.432022e-01 | 0.129 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.447329e-01 | 0.128 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 7.447329e-01 | 0.128 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 7.447329e-01 | 0.128 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 7.447329e-01 | 0.128 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.447329e-01 | 0.128 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 7.447329e-01 | 0.128 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 7.447329e-01 | 0.128 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.447329e-01 | 0.128 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 7.447329e-01 | 0.128 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 7.538338e-01 | 0.123 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 7.569957e-01 | 0.121 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 7.569957e-01 | 0.121 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 7.578035e-01 | 0.120 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 7.578035e-01 | 0.120 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 7.578035e-01 | 0.120 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 7.578035e-01 | 0.120 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 7.578035e-01 | 0.120 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 7.578035e-01 | 0.120 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 7.662000e-01 | 0.116 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 7.662000e-01 | 0.116 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.702056e-01 | 0.113 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.702056e-01 | 0.113 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 7.702056e-01 | 0.113 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 7.702056e-01 | 0.113 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 7.702056e-01 | 0.113 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.702056e-01 | 0.113 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.702056e-01 | 0.113 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 7.714949e-01 | 0.113 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 7.750998e-01 | 0.111 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 7.750998e-01 | 0.111 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 7.781746e-01 | 0.109 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 7.819135e-01 | 0.107 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 7.819734e-01 | 0.107 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 7.819734e-01 | 0.107 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 7.819734e-01 | 0.107 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 7.819734e-01 | 0.107 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 7.839770e-01 | 0.106 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 7.896613e-01 | 0.103 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 7.931392e-01 | 0.101 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 7.931392e-01 | 0.101 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.931392e-01 | 0.101 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 7.931392e-01 | 0.101 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 7.931392e-01 | 0.101 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 7.931392e-01 | 0.101 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 7.943418e-01 | 0.100 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 8.000422e-01 | 0.097 | 0 | 0 |
| Translation | R-HSA-72766 | 8.025135e-01 | 0.096 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 8.037338e-01 | 0.095 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 8.037338e-01 | 0.095 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 8.037338e-01 | 0.095 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 8.037338e-01 | 0.095 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.037338e-01 | 0.095 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.037338e-01 | 0.095 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 8.037338e-01 | 0.095 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 8.037338e-01 | 0.095 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 8.119093e-01 | 0.090 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 8.137864e-01 | 0.089 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 8.137864e-01 | 0.089 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.137864e-01 | 0.089 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 8.137864e-01 | 0.089 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 8.137864e-01 | 0.089 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 8.137864e-01 | 0.089 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 8.152782e-01 | 0.089 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 8.152782e-01 | 0.089 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 8.163466e-01 | 0.088 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 8.225001e-01 | 0.085 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 8.233247e-01 | 0.084 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 8.233247e-01 | 0.084 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 8.233247e-01 | 0.084 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 8.233247e-01 | 0.084 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 8.233247e-01 | 0.084 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 8.233247e-01 | 0.084 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 8.233247e-01 | 0.084 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 8.233247e-01 | 0.084 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 8.294675e-01 | 0.081 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 8.309746e-01 | 0.080 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 8.309746e-01 | 0.080 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 8.309746e-01 | 0.080 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.323750e-01 | 0.080 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.323750e-01 | 0.080 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 8.334028e-01 | 0.079 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 8.361874e-01 | 0.078 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 8.409622e-01 | 0.075 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 8.409622e-01 | 0.075 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.409622e-01 | 0.075 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 8.409622e-01 | 0.075 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 8.409622e-01 | 0.075 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 8.409622e-01 | 0.075 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 8.491099e-01 | 0.071 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.491099e-01 | 0.071 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 8.491099e-01 | 0.071 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.491099e-01 | 0.071 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 8.491099e-01 | 0.071 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.558476e-01 | 0.068 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 8.558476e-01 | 0.068 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 8.568408e-01 | 0.067 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.568408e-01 | 0.067 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.607331e-01 | 0.065 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 8.641759e-01 | 0.063 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 8.641759e-01 | 0.063 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.660875e-01 | 0.062 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 8.663202e-01 | 0.062 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 8.703087e-01 | 0.060 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 8.711357e-01 | 0.060 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 8.711357e-01 | 0.060 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 8.711357e-01 | 0.060 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.777392e-01 | 0.057 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.777392e-01 | 0.057 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.777392e-01 | 0.057 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 8.801924e-01 | 0.055 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.818688e-01 | 0.055 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 8.840048e-01 | 0.054 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 8.840048e-01 | 0.054 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 8.840048e-01 | 0.054 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.840048e-01 | 0.054 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 8.840048e-01 | 0.054 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 8.840048e-01 | 0.054 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.840048e-01 | 0.054 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 8.840048e-01 | 0.054 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.840048e-01 | 0.054 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 8.895489e-01 | 0.051 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.899495e-01 | 0.051 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.899495e-01 | 0.051 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 8.899495e-01 | 0.051 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.902598e-01 | 0.050 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 8.915751e-01 | 0.050 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 8.915751e-01 | 0.050 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 8.955900e-01 | 0.048 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 8.955900e-01 | 0.048 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.955900e-01 | 0.048 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 8.955900e-01 | 0.048 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 8.955900e-01 | 0.048 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.962571e-01 | 0.048 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.991494e-01 | 0.046 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.000042e-01 | 0.046 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.009417e-01 | 0.045 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.009417e-01 | 0.045 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.009417e-01 | 0.045 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.009417e-01 | 0.045 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.041141e-01 | 0.044 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.060194e-01 | 0.043 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 9.060194e-01 | 0.043 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.060194e-01 | 0.043 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.060194e-01 | 0.043 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.108371e-01 | 0.041 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.108371e-01 | 0.041 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 9.108371e-01 | 0.041 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.129335e-01 | 0.040 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.154081e-01 | 0.038 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.154081e-01 | 0.038 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.155162e-01 | 0.038 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.155162e-01 | 0.038 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.197450e-01 | 0.036 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.223966e-01 | 0.035 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.233649e-01 | 0.035 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.238599e-01 | 0.034 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.277640e-01 | 0.033 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.277640e-01 | 0.033 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.277640e-01 | 0.033 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 9.277640e-01 | 0.033 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.314681e-01 | 0.031 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.317346e-01 | 0.031 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.349825e-01 | 0.029 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.349825e-01 | 0.029 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.383169e-01 | 0.028 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.383169e-01 | 0.028 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.383169e-01 | 0.028 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.400026e-01 | 0.027 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 9.414805e-01 | 0.026 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.414805e-01 | 0.026 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.414805e-01 | 0.026 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.414805e-01 | 0.026 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.424246e-01 | 0.026 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.452285e-01 | 0.024 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.473138e-01 | 0.024 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.473297e-01 | 0.023 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.500316e-01 | 0.022 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.517646e-01 | 0.021 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.536078e-01 | 0.021 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.536078e-01 | 0.021 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.550270e-01 | 0.020 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 9.573344e-01 | 0.019 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.652633e-01 | 0.015 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.652633e-01 | 0.015 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.704933e-01 | 0.013 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.704933e-01 | 0.013 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.704933e-01 | 0.013 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.715547e-01 | 0.013 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.720079e-01 | 0.012 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.720079e-01 | 0.012 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.720079e-01 | 0.012 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.720079e-01 | 0.012 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.723181e-01 | 0.012 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.734449e-01 | 0.012 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 9.748082e-01 | 0.011 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.806448e-01 | 0.008 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.816388e-01 | 0.008 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.838417e-01 | 0.007 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.843252e-01 | 0.007 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.855275e-01 | 0.006 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.855499e-01 | 0.006 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.867880e-01 | 0.006 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.873065e-01 | 0.006 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.888145e-01 | 0.005 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.891644e-01 | 0.005 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.891644e-01 | 0.005 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.909622e-01 | 0.004 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.912307e-01 | 0.004 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.925471e-01 | 0.003 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.936076e-01 | 0.003 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.938199e-01 | 0.003 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.940405e-01 | 0.003 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.942351e-01 | 0.003 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.945439e-01 | 0.002 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.958101e-01 | 0.002 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.958101e-01 | 0.002 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.964241e-01 | 0.002 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.967826e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.969482e-01 | 0.001 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.971342e-01 | 0.001 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.972703e-01 | 0.001 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.973956e-01 | 0.001 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.975296e-01 | 0.001 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.983810e-01 | 0.001 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.983816e-01 | 0.001 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.984649e-01 | 0.001 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.985963e-01 | 0.001 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.986814e-01 | 0.001 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.987576e-01 | 0.001 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.988253e-01 | 0.001 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.989628e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.989945e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.993027e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.994077e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.994665e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.995562e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.995562e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.997178e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.997192e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.997582e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.997636e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.997657e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.998134e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.998863e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999153e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999636e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999696e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999976e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999981e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999994e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999999e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999999e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |